<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.4.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art540.dtd?><?SourceDTD.Version 5.4.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 2?><?origin publisher?><?FILEmeta_NP6085 xml ?><?FILEmain xml ?><?FILEgr1 jpg ?><?FILEgr2 jpg ?><?FILEgr3 jpg ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEgr7 jpg ?><?FILEsi1 gif ?><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropharmacology</journal-id><journal-id journal-id-type="iso-abbrev">Neuropharmacology</journal-id><journal-title-group><journal-title>Neuropharmacology</journal-title></journal-title-group><issn pub-type="ppub">0028-3908</issn><issn pub-type="epub">1873-7064</issn><publisher><publisher-name>Pergamon Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4764649</article-id><article-id pub-id-type="publisher-id">S0028-3908(15)30183-0</article-id><article-id pub-id-type="doi">10.1016/j.neuropharm.2015.11.019</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>During postnatal development endogenous neurosteroids influence GABA-ergic neurotransmission of mouse cortical neurons </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Adam R.</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref><xref rid="fn2" ref-type="fn">2</xref></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Scott J.</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="fn2" ref-type="fn">2</xref></contrib><contrib contrib-type="author"><name><surname>Peden</surname><given-names>Dianne R.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Herd</surname><given-names>Murray B.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Seifi</surname><given-names>Mohsen</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Swinny</surname><given-names>Jerome D.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Belelli</surname><given-names>Delia</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Lambert</surname><given-names>Jeremy J.</given-names></name><email>j.j.lambert@dundee.ac.uk</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">∗</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Division of Neuroscience, Medical Research Institute, Ninewells Hospital &amp; Medical School, Dundee University, Dundee, UK</aff><aff id="aff2"><label>b</label>Institute for Biomedical and Biomolecular Sciences, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK</aff><author-notes><corresp id="cor1"><label>∗</label>Corresponding author. Division of Neuroscience, Medical Research Institute, Ninewells Hospital &amp; Medical School, Dundee University, Dundee, DD1 9SY, UK.Division of NeuroscienceMedical Research InstituteNinewells Hospital &amp; Medical SchoolDundee UniversityDundeeDD1 9SYUK <email>j.j.lambert@dundee.ac.uk</email></corresp><fn id="fn1"><label>1</label><p id="ntpara0010"><text><SENT sid="1" pm="."><plain>Current address: Pfizer NPRU, The Portway, Granta Park, Cambridge, UK. </plain></SENT>
</text></p></fn><fn id="fn2"><label>2</label><p id="ntpara0015"><text><SENT sid="2" pm="."><plain>Joint First Authors. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>103</volume><fpage>163</fpage><lpage>173</lpage><history><date date-type="received"><day>13</day><month>4</month><year>2015</year></date><date date-type="rev-recd"><day>11</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>© 2015 The Authors</copyright-statement><copyright-year>2015</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="3" pm="."><plain>As neuronal development progresses, GABAergic synaptic transmission undergoes a defined program of reconfiguration. </plain></SENT>
<SENT sid="4" pm="."><plain>For example, GABAA receptor (GABAAR)-mediated synaptic currents, (miniature inhibitory postsynaptic currents; mIPSCs), which initially exhibit a relatively slow decay phase, become progressively reduced in duration, thereby supporting the temporal resolution required for mature network activity. </plain></SENT>
<SENT sid="5" pm="."><plain>Here we report that during postnatal development of cortical layer 2/3 pyramidal neurons, GABAAR-mediated phasic inhibition is influenced by a resident neurosteroid tone, which wanes in the second postnatal week, resulting in the brief phasic events characteristic of mature neuronal signalling. </plain></SENT>
<SENT sid="6" pm="."><plain>Treatment of cortical slices with the immediate precursor of 5α-pregnan-3α-ol-20-one (5α3α), the GABAAR-inactive 5α-dihydroprogesterone, (5α-DHP), greatly prolonged the mIPSCs of P20 pyramidal neurons, demonstrating these more mature neurons retain the capacity to synthesize GABAAR-active neurosteroids, but now lack the endogenous steroid substrate. </plain></SENT>
<SENT sid="7" pm="."><plain>Previously, such developmental plasticity of phasic inhibition was ascribed to the expression of synaptic GABAARs incorporating the α1 subunit. </plain></SENT>
<SENT sid="8" pm="."><plain>However, the duration of mIPSCs recorded from L2/3 cortical neurons derived from α1 subunit deleted mice, were similarly under the developmental influence of a neurosteroid tone. </plain></SENT>
<SENT sid="9" pm="."><plain>In addition to principal cells, synaptic GABAARs of L2/3 interneurons were modulated by native neurosteroids in a development-dependent manner. </plain></SENT>
<SENT sid="10" pm="."><plain>In summary, local neurosteroids influence synaptic transmission during a crucial period of cortical neurodevelopment, findings which may be of importance for establishing normal network connectivity. </plain></SENT>
</text></SecTag></p></abstract><abstract abstract-type="author-highlights"><title><text><SENT sid="11" pm="."><plain>Highlights </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="12" pm="."><plain>•Upon postnatal maturation GABAA receptor synaptic inhibition is reduced in duration.•Reduced synthesis of local neurosteroids contributes to this cortical plasticity.•The study reveals a potent mechanism to locally regulate cortical neuron activity. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><title>Keywords</title><kwd>GABA<sub>A</sub> receptor</kwd><kwd>Neurosteroid</kwd><kwd>Neonatal development</kwd><kwd>Cortex</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="ABBR"><sec id="nomen0010"><title><text><SENT sid="13" pm="."><plain>Abbreviations </plain></SENT>
</text></title><def-list><def-item><term>α1<sup>−/−</sup></term><def><p><text><SENT sid="14" pm="."><plain>GABAAR α1 subunit “knockout”. </plain></SENT>
</text></p></def></def-item><def-item><term>5α3α</term><def><p><text><SENT sid="15" pm="."><plain>5α-pregnan-3α-ol-20-one; allopregnanolone. </plain></SENT>
</text></p></def></def-item><def-item><term>5α-DHP</term><def><p><text><SENT sid="16" pm="."><plain>5α-dihydroprogesterone, or 5α-pregnane-3,20-dione. </plain></SENT>
</text></p></def></def-item><def-item><term>5α-R</term><def><p><text><SENT sid="17" pm="."><plain>5α-reductase. </plain></SENT>
</text></p></def></def-item><def-item><term>CD</term><def><p><text><SENT sid="18" pm="."><plain>cyclodextrin </plain></SENT>
</text></p></def></def-item><def-item><term>τ<sub>w</sub></term><def><p><text><SENT sid="19" pm="."><plain>weighted decay time constant of mIPSC decay. </plain></SENT>
</text></p></def></def-item><def-item><term>aCSF</term><def><p><text><SENT sid="20" pm="."><plain>artificial cerebrospinal fluid. </plain></SENT>
</text></p></def></def-item><def-item><term>ANOVA</term><def><p><text><SENT sid="21" pm="."><plain>analysis of variance statistical test. </plain></SENT>
</text></p></def></def-item><def-item><term>DMSO</term><def><p><text><SENT sid="22" pm="."><plain>dimethylsulphoxide. </plain></SENT>
</text></p></def></def-item><def-item><term>ECS</term><def><p><text><SENT sid="23" pm="."><plain>extracellular solution. </plain></SENT>
</text></p></def></def-item><def-item><term>GABA</term><def><p><text><SENT sid="24" pm="."><plain>γ-aminobutyric acid. </plain></SENT>
</text></p></def></def-item><def-item><term>GABA<sub>A</sub>R</term><def><p><text><SENT sid="25" pm="."><plain>γ-aminobutyric acid type A receptor. </plain></SENT>
</text></p></def></def-item><def-item><term>GAD67-GFP</term><def><p><text><SENT sid="26" pm="."><plain>glutamic acid decarboxylase-green fluorescent protein. </plain></SENT>
</text></p></def></def-item><def-item><term>ICS</term><def><p><text><SENT sid="27" pm="."><plain>intracellular solution. </plain></SENT>
</text></p></def></def-item><def-item><term>KS</term><def><p><text><SENT sid="28" pm="."><plain>Kolmogorov–Smirnov statistical test. </plain></SENT>
</text></p></def></def-item><def-item><term>L2/3</term><def><p><text><SENT sid="29" pm="."><plain>cortical layer 2/3. </plain></SENT>
</text></p></def></def-item><def-item><term>mIPSC</term><def><p><text><SENT sid="30" pm="."><plain>miniature inhibitory postsynaptic current. </plain></SENT>
</text></p></def></def-item><def-item><term>P</term><def><p><text><SENT sid="31" pm="."><plain>postnatal day. </plain></SENT>
</text></p></def></def-item><def-item><term>S.E.M</term><def><p><text><SENT sid="32" pm="."><plain>standard error of the mean. </plain></SENT>
</text></p></def></def-item><def-item><term>T50</term><def><p><text><SENT sid="33" pm="."><plain>time taken for mIPSCs to decay from peak amplitude by 50%. </plain></SENT>
</text></p></def></def-item><def-item><term>TTX</term><def><p><text><SENT sid="34" pm="."><plain>tetrodotoxin. </plain></SENT>
</text></p></def></def-item><def-item><term>VB</term><def><p><text><SENT sid="35" pm="."><plain>ventrobasal. </plain></SENT>
</text></p></def></def-item></def-list></sec></SecTag><SecTag type="INTRO"><sec id="sec1"><label>1</label><title><text><SENT sid="36" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="37" pm="."><plain>The postnatal brain undergoes considerable neuronal plasticity to meet the changing demands of rapidly developing networks. </plain></SENT>
<SENT sid="38" pm="."><plain>During this critical time the duration of synaptic events mediated by GABAARs becomes progressively reduced, permitting postsynaptic neurons to respond to input from certain fast-spiking GABA-ergic interneurons and thereby appropriately influence the temporal window for postsynaptic excitation (Whittington et al., 2011, Deidda et al., 2014, Fritschy and Panzanelli, 2014). </plain></SENT>
<SENT sid="39" pm="."><plain>Alterations to the subunit composition of synaptic GABAARs are implicated in producing these crucial changes to inhibitory postsynaptic current (IPSC) kinetics (Brickley et al., 1996, Okada et al., 2000, Vicini et al., 2001, Juttner et al., 2001, Goldstein et al., 2002, Bosman et al., 2005; Takahashi, 2005, Fritschy and Panzanelli, 2014, Deidda et al., 2014). </plain></SENT>
<SENT sid="40" pm="."><plain>GABAARs are members of the Cys-loop transmitter-gated ion channel family and in common with glycine, nicotinic acetylcholine and 5HT3 receptors are composed of five subunits (Olsen and Sieghart, 2008). </plain></SENT>
<SENT sid="41" pm="."><plain>In mammals 19 subunit genes underpin the expression of ∼20–30 native GABAAR subtypes, which display distinct pharmacological and physiological properties (Olsen and Sieghart, 2008). </plain></SENT>
<SENT sid="42" pm="."><plain>In the CNS, these GABAAR subtypes exhibit a heterogeneous expression pattern, which importantly in many neurons is known to change during neonatal development (Olsen and Sieghart, 2008, Fritschy and Panzanelli, 2014, Rudolph and Mohler, 2014). </plain></SENT>
<SENT sid="43" pm="."><plain>In particular, an increased expression of receptors incorporating the α1 subunit (α1-GABAARs) is implicated in the appearance of short duration IPSCs (Okada et al., 2000, Vicini et al., 2001, Peden et al., 2008, Eyre et al., 2012, Deidda et al., 2014, Fritschy and Panzanelli, 2014). </plain></SENT>
<SENT sid="44" pm="."><plain>However, during development of thalamocortical inhibitory synapses, changes to IPSC kinetics occur prior to the temporal expression of the α1 subunit (Peden et al., 2008, Brown et al., 2015), implicating, at least in these neurons, additional factor(s) that influence GABAAR ion channel gating properties. </plain></SENT>
</text></p><p><text><SENT sid="45" pm="."><plain>Certain naturally occurring neurosteroids act in a non-genomic manner as endogenous positive allosteric modulators of the GABAAR (Belelli and Lambert, 2005, Zorumski et al., 2013). </plain></SENT>
<SENT sid="46" pm="."><plain>The cortical levels of these neurosteroids change during neonatal development (Grobin and Morrow, 2001). </plain></SENT>
<SENT sid="47" pm="."><plain>Furthermore, the enzymes required to synthesize these GABAAR-active steroids are expressed in certain neurons, suggesting that these local neuromodulators may act as paracrine, or autocrine messengers, to locally influence neuronal inhibition (Agis-Balboa et al., 2006, Do Rego et al., 2009, Castelli et al., 2013, Brown et al., 2015). </plain></SENT>
<SENT sid="48" pm="."><plain>Here, we demonstrate for mouse cortical L2/3 pyramidal neurons and interneurons that during early (P7-15) neonatal development, their synaptic GABAARs are influenced by an endogenous neurosteroid tone, which consequently prolongs the duration of phasic GABAergic neurotransmission. </plain></SENT>
<SENT sid="49" pm="."><plain>During subsequent development this modulation wanes, such that by P20-24 it has dissipated, resulting in brief IPSCs, characteristic of mature inhibitory synapses. </plain></SENT>
<SENT sid="50" pm="."><plain>However, when provided with 5α-dihydroprogesterone (5α-DHP), the 5α3α precursor, these more mature neurons retain the capacity to synthesise GABAAR-active neurosteroids, suggesting that the developmental changes to GABAergic neurotransmission reflect a timed loss of steroid substrate, acting in concert with the established ontogenetic pattern of α1 subunit expression. </plain></SENT>
<SENT sid="51" pm="."><plain>Importantly, neurosteroid levels are not static, but are perturbed in a variety of physiological and pathophysiological conditions (Belelli and Lambert, 2005, Zorumski et al., 2013). </plain></SENT>
<SENT sid="52" pm="."><plain>Therefore, given the role GABAARs may play in a number of disorders including autism, schizophrenia, Fragile X and Down syndrome (Deidda et al., 2014, Rudolph and Mohler, 2014), these findings may not only be important in better understanding how phasic GABAergic neurotransmission changes to accommodate the demands of neuronal network activity during development, but may additionally allow new insights into the pathology of certain neurodevelopmental disorders. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec2"><label>2</label><title><text><SENT sid="53" pm="."><plain>Materials &amp; methods </plain></SENT>
</text></title><sec id="sec2.1"><label>2.1</label><title><text><SENT sid="54" pm="."><plain>Breeding of mice </plain></SENT>
</text></title><p><text><SENT sid="55" pm="."><plain>All animal studies were approved by the University of Dundee Ethical Review Committee (Home Office Project Licenses 60/4005 and 70/8161, Dr. Belelli), and complied with Schedule 1 of the UK Government Animals (Scientific Procedures) Act, 1986. </plain></SENT>
<SENT sid="56" pm="."><plain>Transgenic α1 subunit ‘knockout’ (α1−/−) mice were generated on a mixed C57BL6-129SvEv background (Sur et al. </plain></SENT>
<SENT sid="57" pm="."><plain>2001). </plain></SENT>
<SENT sid="58" pm="."><plain>Transgenic GAD 67-GFP “knock-in” mice were generated on a C57BL/6J background as described previously (Tamamaki et al. </plain></SENT>
<SENT sid="59" pm="."><plain>2003). </plain></SENT>
<SENT sid="60" pm="."><plain>Electrophysiological experiments were performed on brain slices prepared from the first 2–3 generations of α1−/−, GAD67-GFP, or corresponding WT offspring from heterozygous (+/−) breeding pairs housed at the University of Dundee. </plain></SENT>
</text></p></sec><sec id="sec2.2"><label>2.2</label><title><text><SENT sid="61" pm="."><plain>Preparation of brain slices for electrophysiology </plain></SENT>
</text></title><p><text><SENT sid="62" pm="."><plain>Cortical slices were prepared from postnatal day (P) P7 - 24 WT, α1−/−, or GAD 67-GFP mice of either sex. </plain></SENT>
<SENT sid="63" pm="."><plain>Mice were killed by cervical dislocation, the brain dissected and placed in ice-cold oxygenated (95% O2/5%CO2) artificial cerebrospinal fluid (aCSF) containing (in mM): 225 sucrose, 2.95 KCl, 1.25 NaH2PO4, 26 NaHCO3, 0.5 CaCl2, 10 MgSO4, 10 glucose, (pH 7.4; 328–330 mOsm). </plain></SENT>
<SENT sid="64" pm="."><plain>The brain was sectioned in the coronal plane using a Vibratome series 1000 PLUS Sectioning System (Intracell, Royston, Hertfordshire, UK). </plain></SENT>
<SENT sid="65" pm="."><plain>Slices were cut at 300–350 μm thickness for mice of P15, or older, and 400 μm, for younger animals. </plain></SENT>
<SENT sid="66" pm="."><plain>Slices were immediately transferred on to a nylon mesh platform housed within a chamber containing circulating oxygenated extracellular solution (ECS, in mM: 126 NaCl, 26 NaHCO3, 2.95 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 10 glucose [306–309 mOsm]) and allowed to rest at room temperature for a minimum of 1 h before electrophysiological recording. </plain></SENT>
</text></p></sec><sec id="sec2.3"><label>2.3</label><title><text><SENT sid="67" pm="."><plain>Voltage-clamp recording </plain></SENT>
</text></title><p><text><SENT sid="68" pm="."><plain>During recording, cortical slices were perfused with ECS maintained at 35 °C using a gravity based perfusion system set to a flow rate of 3–5 ml/min and recycled to a 50 ml oxygenated reservoir using a peristaltic pump (Minipuls 3, Gilson, UK). </plain></SENT>
<SENT sid="69" pm="."><plain>Intracellular solution (ICS) containing (in mM): 135 CsCl, 10 HEPES, 10 EGTA, 2 MgCl2, 1 CaCl2, 2 Mg-ATP and 5 QX-314 (pH 7.2–7.3, 290–300 mOsm) was used for whole-cell recording. </plain></SENT>
<SENT sid="70" pm="."><plain>Patch pipettes were pulled from thick-walled borosilicate glass (0.95 mm I.D. </plain></SENT>
<SENT sid="71" pm="."><plain>1.55 mm E.D. </plain></SENT>
<SENT sid="72" pm="."><plain>Garner Glass Co. </plain></SENT>
<SENT sid="73" pm="."><plain>Claremont, CA), using a Narashige PC-10 electrode puller (Narashige, Japan). </plain></SENT>
<SENT sid="74" pm="."><plain>When filled with the above ICS, pipettes with an open tip resistance of 2–6 MΩ were obtained. </plain></SENT>
<SENT sid="75" pm="."><plain>Neurons were visually identified for investigation using an upright Olympus BX50WI microscope (Olympus, Southall, UK) equipped with IR-DIC optics. </plain></SENT>
<SENT sid="76" pm="."><plain>Pyramidal neurons located within cortical L2/3 were identified based on their canonical pyramidal morphology. </plain></SENT>
<SENT sid="77" pm="."><plain>L2/3 GABAergic interneurons were identified in cortical slices derived from GAD67-GFP “knock-in” mice using epifluorescence microscopy. </plain></SENT>
<SENT sid="78" pm="."><plain>Neurons were voltage-clamped at −60 mV using an Axopatch 1D amplifier (Molecular Devices, CA, USA) and filtered at 2 kHz. </plain></SENT>
<SENT sid="79" pm="."><plain>GABAAR-mediated mIPSCs were isolated by supplementing the ECS with kynurenic acid (2 mM), tetrodotoxin (TTX, 500 nM) and strychnine (1 μM). </plain></SENT>
<SENT sid="80" pm="."><plain>Data was acquired and digitised (10 kHz) using a NIDAQ mx card (National Instruments, TX, USA) and stored directly to PC using WinEDR software (Strathclyde University, UK). </plain></SENT>
<SENT sid="81" pm="."><plain>Series resistance compensation was applied up to 80%. </plain></SENT>
<SENT sid="82" pm="."><plain>Recordings were omitted from analysis if the series resistance changed by more than 20% during the experiment, or if they exceeded 15 MΩ. </plain></SENT>
</text></p></sec><sec id="sec2.4"><label>2.4</label><title><text><SENT sid="83" pm="."><plain>Drugs and reagents </plain></SENT>
</text></title><p><text><SENT sid="84" pm="."><plain>For in vitro experiments, finasteride, indomethacin, 5α3α and 5α-DHP were prepared as concentrated stock solutions (1000x final concentration) in DMSO, whereas bicuculline methobromide and TTX were prepared as concentrated stock solutions in distilled water. </plain></SENT>
<SENT sid="85" pm="."><plain>Drug stock solutions were diluted to the final required concentration in ECS, whereas kynurenic acid was dissolved directly into the ECS. </plain></SENT>
<SENT sid="86" pm="."><plain>Similarly, α-CD and γ-CD were dissolved directly into the extracellular and intracellular solution. </plain></SENT>
</text></p><p><text><SENT sid="87" pm="."><plain>For acute studies with 5α3α (1 μM), the steroid was perfused directly in to the recording chamber, with the effect determined on mIPSCs acquired after ∼ 7 min of drug contact with the slice preparation. </plain></SENT>
<SENT sid="88" pm="."><plain>To investigate the impact of prolonged exposure to either 5α3α (100 nM), or 5α-DHP (3 μM), the test steroid was pre-incubated with the cortical slice at room temperature for &gt; 2 h, before the tissue was transferred to the recording chamber, where it was continuously perfused with ECS (see Section 2.3 above) containing the test steroid. </plain></SENT>
<SENT sid="89" pm="."><plain>Note for some experiments with 5α-DHP (3 μM) the cortical slice was co-incubated with indomethacin (100 μM). </plain></SENT>
<SENT sid="90" pm="."><plain>The CD studies employed two protocols: the first involved pre-incubating cortical slices in the holding chamber at room temperature with either α-, or γ-CD (1 mM, &gt;1 h). </plain></SENT>
<SENT sid="91" pm="."><plain>Recordings were then made with both ECS and ICS containing the CD (1 and 0.5 mM, respectively). </plain></SENT>
<SENT sid="92" pm="."><plain>In the second protocol, CD was included only in the recording pipette (0.5 mM). </plain></SENT>
<SENT sid="93" pm="."><plain>When the CD was applied to the intracellular compartment alone, mIPSCs were only included for analysis if they were recorded for at least 6 min after obtaining whole-cell access. </plain></SENT>
<SENT sid="94" pm="."><plain>To examine the influence of inhibiting the 5α-R enzyme, finasteride (50 μM) was pre-incubated with the cortical slice in a holding chamber containing oxygenated ECS (at room temperature) for &gt; than 4 h prior to recording. </plain></SENT>
<SENT sid="95" pm="."><plain>Subsequent recordings from such slices were made either with a control intracellular pipette solution, or with the pipette containing γ-CD, to determine the combined influence of intracellular γ-CD and finasteride treatment. </plain></SENT>
<SENT sid="96" pm="."><plain>Note the final DMSO concentration (0.1%) had no effect on any of the mIPSC parameters measured. </plain></SENT>
</text></p></sec><sec id="sec2.5"><label>2.5</label><title><text><SENT sid="97" pm="."><plain>Electrophysiological analysis </plain></SENT>
</text></title><p><text><SENT sid="98" pm="."><plain>Digitized data was analysed offline using WinEDR/WinWCP software (Strathclyde University, UK). </plain></SENT>
<SENT sid="99" pm="."><plain>The mIPSCs were identified by an algorithmic detection protocol. </plain></SENT>
<SENT sid="100" pm="."><plain>To eliminate distal events, which may be affected by imperfect voltage-clamp, Gaussian distributions of 10–90% rise time were generated and mIPSCs falling outside the Gaussian limits were excluded. </plain></SENT>
<SENT sid="101" pm="."><plain>Individual mIPSCs were visually inspected and spurious events omitted. </plain></SENT>
<SENT sid="102" pm="."><plain>Typically, for each neuron data from 50, or more mIPSCs were analysed with respect to their peak amplitude, 10–90% rise time, and time taken to decay from peak by 50% (T50). </plain></SENT>
<SENT sid="103" pm="."><plain>Accepted mIPSCs recorded from a single neuron were averaged and fitted with either a mono-exponential (y(t) = Ae(−t/τ)), or bi-exponential (y(t) = A1e(−t/τ1) + A2e(−t/τ2)) decay function, where y(t) is the current amplitude at time t, A is the current amplitude and τ is the decay time constant. </plain></SENT>
<SENT sid="104" pm="."><plain>To compare goodness of fit between a mono- or bi-exponential decay, an F test was applied to the standard deviation of the residuals. </plain></SENT>
<SENT sid="105" pm="."><plain>The overwhelming majority of mIPSC decay times analysed were best fit by a bi-exponential function. </plain></SENT>
<SENT sid="106" pm="."><plain>Subsequently, a mean weighted decay constant (τw) was calculated to accommodate the relative contribution of each decay component whereby:τw = τ1P1+τ2P2 </plain></SENT>
</text></p><p><text><SENT sid="107" pm="."><plain>Here, τ1 and τ2 are the decay time constants for the first and second exponential functions, and P1 and P2 are the proportions of current amplitude described by each component i.e.P1=A1A1+A2P2=A2A1+A2 </plain></SENT>
</text></p><p><text><SENT sid="108" pm="."><plain>All reported data are expressed as mean values ± standard error of the mean (S.E.M.). </plain></SENT>
<SENT sid="109" pm="."><plain>To determine statistical significance, Student's t-tests (paired, or unpaired) and ANOVA (one or two-way, followed post-hoc by Tukey's HSD or independent samples t-test, SigmaStat, Systat Software Inc. </plain></SENT>
<SENT sid="110" pm="."><plain>San Jose, CA, USA) were used as appropriate. </plain></SENT>
<SENT sid="111" pm="."><plain>For comparison of cumulative probability distributions of mIPSC T50 values, the Kolmogorov-Smirnoff (KS) test was used (SPSS software, Chicago, IL, USA). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="sec3"><label>3</label><title><text><SENT sid="112" pm="."><plain>Results </plain></SENT>
</text></title><sec id="sec3.1"><label>3.1</label><title><text><SENT sid="113" pm="."><plain>The influence of development on phasic currents, mediated by synaptic GABAARs of L2/3 cortical pyramidal neurons </plain></SENT>
</text></title><p><text><SENT sid="114" pm="."><plain>The properties of mIPSCs (frequency, amplitude and kinetics), recorded from WT L2/3 pyramidal neurons, obtained from neonatal/juvenile (P7 - 15) to adolescent (P20 - 24) mice, changed with development (Fig. 1; Table 1). </plain></SENT>
<SENT sid="115" pm="."><plain>Of particular note, with age the mIPSC frequency increased considerably (e.g. P7 - 8 = 1.2 ± 0.2 Hz, n = 55 neurons; P20 - 24 = 11.7 ± 1.2 Hz, n = 25 neurons – Fig. 1; Table 1). </plain></SENT>
<SENT sid="116" pm="."><plain>Furthermore, the mIPSC decay time, as quantified by determination of the weighted decay time constant (τW), decreased with development. </plain></SENT>
<SENT sid="117" pm="."><plain>Specifically, P7 - 8 neurons exhibited mIPSCs with a relatively prolonged decay (τW = 12.1 ± 0.3 ms; n = 55), that by P15 had become significantly reduced (τW = 6.5 ± 0.3 ms; n = 14; one way ANOVA; p &lt; 0.001 vs P7 - 8, Fig. 1C, Table 1). </plain></SENT>
<SENT sid="118" pm="."><plain>With the profile of mIPSC decay kinetics between P7 - 8 and P20 - 24 established, investigations now focused on whether the mIPSCs of L2/3 pyramidal neurons are influenced by endogenous neurosteroids. </plain></SENT>
</text></p></sec><sec id="sec3.2"><label>3.2</label><title><text><SENT sid="119" pm="."><plain>Phasic GABAergic transmission from P7 - 8 cortical L2/3 pyramidal neurons is influenced by an endogenous neurosteroid tone </plain></SENT>
</text></title><p><text><SENT sid="120" pm="."><plain>To test for endogenous modulation of GABAergic neurotransmission by neurosteroids, we utilized γ-CD, a neurosteroid scavenger (Shu et al., 2007, Brown et al., 2015). </plain></SENT>
<SENT sid="121" pm="."><plain>For P7 - 8 neurons, the γ-CD pre-incubation protocol (&gt;1 h. see Methods) had no effect on the mIPSC frequency, or amplitude (in both cases p &gt; 0.05, one way ANOVA), but greatly reduced their duration (τW control = 12.1 ± 0.3 ms, n = 55, vs τW γ-CD = 8.5 ± 0.2 ms, n = 20, p &lt; 0.001, one way ANOVA, Fig. 2A, F, G Table 1). </plain></SENT>
<SENT sid="122" pm="."><plain>The structurally related α-CD is ineffective in sequestering pregnane steroids, as the pore diameter of the molecule is smaller (6 vs 8 cyclic sugars) than that of γ-CD (Davis and Brewster, 2004, Shu et al., 2004, Shu et al., 2007, Brown et al., 2015). </plain></SENT>
<SENT sid="123" pm="."><plain>Importantly, the equivalent treatment with α-CD had no effect on the mIPSC τW of P7 - 8 neurons (p &gt; 0.05, one way ANOVA, Fig. 2B, F, G). </plain></SENT>
</text></p><p><text><SENT sid="124" pm="."><plain>To confirm that the reduced decay times observed following γ-CD were due to neurosteroid sequestration, we pre-incubated P7 - 8 WT cortical brain slices with the 5α-reductase inhibitor finasteride (50 μM &gt; 4 h), which significantly reduced the mIPSC duration (τW control = 12.1 ± 0.3 ms, n = 55; τW finasteride = 8.5 ± 0.3 ms, n = 7, p &lt; 0.001, one way ANOVA, Fig. 2C, F, G, Table 1). </plain></SENT>
<SENT sid="125" pm="."><plain>This effect on the mIPSC duration was indistinguishable from that produced by γ-CD (finasteride τW = 8.5 ± 0.3 ms, n = 7, γ-CD τW = 8.5 ± 0.2 ms, n = 20; p &gt; 0.05, one way ANOVA, Fig. 2F, G, Table 1). </plain></SENT>
<SENT sid="126" pm="."><plain>Collectively, these findings indicate that an endogenous neurosteroid tone influences synaptic GABAARs at P7 – 8. </plain></SENT>
</text></p><p><text><SENT sid="127" pm="."><plain>Interpretation of the combined effects of finasteride and γ-CD is potentially complicated, as given that finasteride is a steroid, it is conceivable that the extracellular γ-CD may sequester this 5α-reductase inhibitor. </plain></SENT>
<SENT sid="128" pm="."><plain>We have previously demonstrated that intracellular γ-CD alone is equi-effective in influencing the mIPSCs of developing thalamic neurons (Brown et al., 2015), suggesting a protocol to avoid this complexity. </plain></SENT>
<SENT sid="129" pm="."><plain>Therefore, we first investigated the effect on cortical mIPSCs of incorporating the membrane-impermeant γ-CD (0.5 mM) solely in the recording pipette (ICS γ-CD). </plain></SENT>
<SENT sid="130" pm="."><plain>This treatment (recordings made &gt; 6 min after achieving the whole-cell recording configuration) significantly reduced the mIPSC τW (control = 12.1 ± 0.3 ms, n = 55; γ-CD ICS: 9.2 ± 0.6 ms, n = 6, p &lt; 0.05, one way ANOVA, Fig. 2D, F, G), an effect indistinguishable from that of γ-CD resulting from the pre-incubation protocol (γ-CD pre-incubation: 8.5 ± 0.2 ms, n = 20, p &gt; 0.05, one way ANOVA, Fig. 2F, G) and not significantly different from that produced by finasteride (50 μM) treatment (p &gt; 0.05, one way ANOVA τW = 8.5 ± 0.3 ms, n = 7, Fig. 2F, G). </plain></SENT>
<SENT sid="131" pm="."><plain>Finally, we now determined the combined effect of finasteride and γ-CD treatment. </plain></SENT>
<SENT sid="132" pm="."><plain>For P7 - 8 neurons, treatment of the slice with finasteride (50 μM) for &gt; 4 h, followed by intracellular γ-CD (0.5 mM), resulted in mIPSCs with a significantly reduced duration (τw = 7.3 ± 0.2 ms; n = 6, p &lt; 0.001, one way ANOVA), that was not significantly different from that produced solely by finasteride, or by intracellular γ-CD alone (p &gt; 0.05, one way ANOVA, Fig. 2E, F, G). </plain></SENT>
</text></p></sec><sec id="sec3.3"><label>3.3</label><title><text><SENT sid="133" pm="."><plain>The neurosteroid influence on phasic–GABAergic transmission of cortical L2/3 pyramidal neurons changes during development </plain></SENT>
</text></title><p><text><SENT sid="134" pm="."><plain>We next assessed whether neurosteroids contribute to the developmental changes in the duration of phasic GABAergic events by determining the effect of γ-CD on the mIPSCs of neurons at different stages of development (Brown et al. </plain></SENT>
<SENT sid="135" pm="."><plain>2015). </plain></SENT>
<SENT sid="136" pm="."><plain>Treatment with γ-CD reduced the decay time of mIPSCs recorded from P7 - 8, P10 and P15 neurons, relative to their respective controls (Fig. 3, Table 1). </plain></SENT>
<SENT sid="137" pm="."><plain>However, the developmental stage significantly influenced the effect of γ-CD on the mIPSC decay time (Fig. 3, age × treatment interaction, F3,157 = 6.15, p &lt; 0.001, two-way ANOVA), such that by P20-24, γ-CD had no significant effect (control τw = 5.4 ± 0.2 ms n = 25; γ-CD = 5.3  ± 0.6 ms; n = 8; p &gt; 0.05; independent samples t-test, Fig. 3). </plain></SENT>
<SENT sid="138" pm="."><plain>Further implicating a changing neurosteroid impact during development, the effect of finasteride (50 μM) was also significantly influenced by post-natal age (Fig. 3, age × treatment interaction, F2,127 = 10.47, p &lt; 0.001, two-way ANOVA), such that, in contrast to P7 – P8 recordings, finasteride had no significant effect on the mIPSC duration of P20 – P24 neurons (control τW = 5.4 ± 0.2 ms; n = 25; finasteride τW = 5.3 ± 0.2 ms; n = 6; p &gt; 0.05, post-hoc Tukey HSD, Fig. 3). </plain></SENT>
</text></p></sec><sec id="sec3.4"><label>3.4</label><title><text><SENT sid="139" pm="."><plain>Decreased neurosteroid synthesis contributes to the changes to phasic GABAergic transmission evident in P20-24 cortex </plain></SENT>
</text></title><p><text><SENT sid="140" pm="."><plain>The loss of neurosteroid influence on phasic inhibition of P20 - 24 pyramidal neurons, inferred by both the finasteride and γ-CD experiments, may be due to the synaptic GABAARs becoming neurosteroid-insensitive (Koksma et al. </plain></SENT>
<SENT sid="141" pm="."><plain>2003), or alternatively a consequence of a decreased neurosteroid synthesis. </plain></SENT>
<SENT sid="142" pm="."><plain>The neurosteroid interaction with GABAARs may be influenced by factors such as subunit composition and phosphorylation status (Koksma et al., 2003, Belelli and Lambert, 2005). </plain></SENT>
<SENT sid="143" pm="."><plain>We therefore investigated whether GABAARs expressed by P20 - 24 L2/3 pyramidal neurons retained neurosteroid sensitivity. </plain></SENT>
<SENT sid="144" pm="."><plain>The acute bath application of exogenous 5α3α (1 μM, whereby mIPSCs were analysed before, and after ∼ 7 min application of the steroid) resulted in mIPSCs with a significantly prolonged decay phase (control τW: 5.5 ± 0.5 ms vs 1 μM 5α3α τW: 8.7 ± 1.7 ms, n = 7, p &lt; 0.05, paired t-test). </plain></SENT>
<SENT sid="145" pm="."><plain>For isolated single cell studies, acutely applied 5α3α acts at nM aqueous concentrations to enhance GABAAR function (Pistis et al., 1997, Belelli and Lambert, 2005). </plain></SENT>
<SENT sid="146" pm="."><plain>Therefore, the relatively limited effect of acutely applied 5α3α at the relatively high concentration of 1 μM might suggest that these cortical synaptic GABAARs are relatively insensitive to the neurosteroid by P20-24. </plain></SENT>
<SENT sid="147" pm="."><plain>Alternatively, the effect of the steroid when applied acutely to a brain slice may be underestimated. </plain></SENT>
<SENT sid="148" pm="."><plain>In support of the latter, the general anesthetics etomidate and propofol, which in common with neurosteroids are lipophilic and efficacious GABAAR modulators, require several hours to approach equilibrium within in vitro brain slice preparations (Gredell et al., 2004, Benkwitz et al., 2007). </plain></SENT>
<SENT sid="149" pm="."><plain>To ascertain whether the GABA modulatory effects of 5α3α are underestimated when applied acutely to a cortical slice, we determined the effect of a lower concentration (100 nM) of 5α3α on the mIPSCs of P20-24 L2/3 pyramidal neurons, but now pre-incubated (&gt;2 h), before being continuously applied during the recording. </plain></SENT>
<SENT sid="150" pm="."><plain>Employing this protocol, the 10 fold lower concentration of 5α3α (100 nM) produced a clear and large prolongation of the mIPSC decay (control τW = 5.4 ± 0.2 ms, n = 25 vs 5α3α 100 nM τW = 12.6 ± 0.9 ms, n = 5, p &lt; 0.001, one way ANOVA; post-hoc Tukey HSD Fig. 4A, C). </plain></SENT>
<SENT sid="151" pm="."><plain>Importantly, this experiment establishes that P20 - 24 cortical synaptic receptors retain sensitivity to nM aqueous concentrations of this neurosteroid and consequently, the change in mIPSC decay at this stage of development is not due to neurosteroid-insensitive synaptic GABAARs. </plain></SENT>
</text></p><p><text><SENT sid="152" pm="."><plain>To determine whether more mature (P20 - 24) L2/3 cortical pyramidal neurons retain the capacity to synthesize GABAAR-active neurosteroids, we investigated the influence of the GABAAR-inactive steroid 5α-DHP, the immediate precursor of 5α3α (Brown et al. </plain></SENT>
<SENT sid="153" pm="."><plain>2015). </plain></SENT>
<SENT sid="154" pm="."><plain>We had previously shown that a prolonged incubation (&gt;2 h), but not a short incubation (30–60 min) of thalamic slices with 5α-DHP prolonged the mIPSC decay phase of VB neurons (Brown et al. </plain></SENT>
<SENT sid="155" pm="."><plain>2015). </plain></SENT>
<SENT sid="156" pm="."><plain>Here, pre-incubation of the cortical slice with 5α-DHP (3 μM) for &gt; 2 h, followed by continuous perfusion of this steroid during the recording (see Methods), resulted in greatly prolonged mIPSCs (control τW = 5.4 ± 0.2 ms, n = 25 vs 5α-DHP τW = 16.1 ± 0.6 ms, n = 7, p &lt; 0.001, one way ANOVA - see Fig. 4B, C). </plain></SENT>
<SENT sid="157" pm="."><plain>This effect was markedly reduced by co-incubation with the 3α-HSD inhibitor indomethacin (100 μM; τW = 6.3 ± 0.4 ms; n = 6; post hoc Tukey HSD p &lt; 0.001), or by intracellular (0.5 mM) γ-CD (τW = 8.7 ± 0.3 ms; n = 6, post hoc Tukey HSD p &lt; 0.001) - Fig. 4B, C. </plain></SENT>
<SENT sid="158" pm="."><plain>Therefore, when provided with the immediate precursor, cortical tissue from P20-24 mice retains the ability to synthesize GABAAR-active neurosteroids. </plain></SENT>
<SENT sid="159" pm="."><plain>Furthermore, these data provide additional evidence that their synaptic GABAARs remain neurosteroid sensitive. </plain></SENT>
</text></p></sec><sec id="sec3.5"><label>3.5</label><title><text><SENT sid="160" pm="."><plain>Phasic GABAergic transmission of L2/3 pyramidal neurons is influenced both by an endogenous neurosteroid tone and by the subunit composition of synaptic GABAARs </plain></SENT>
</text></title><p><text><SENT sid="161" pm="."><plain>Despite treatment with γ-CD, the mIPSC decay time still decreased with development, with a similar trend observed for finasteride-treated neurons (Fig. 3, Table 1). </plain></SENT>
<SENT sid="162" pm="."><plain>These observations suggest that factors additional to neurosteroids influence phasic inhibition during development. </plain></SENT>
<SENT sid="163" pm="."><plain>Numerous studies have implicated changes to the subunit composition of synaptic GABAARs to be important in this respect, with a particular emphasis on the role of the α1 subunit (Rovira and Ben-Ari, 1993, Tia et al., 1996, Hollrigel and Soltesz, 1997, Dunning et al., 1999, Kapur and Macdonald, 1999, Vicini, 1999, Vicini et al., 2001, Okada et al., 2000, Ortinski et al., 2004). </plain></SENT>
<SENT sid="164" pm="."><plain>To investigate whether α1-GABAARs influence mIPSCs during the development (P7 – 24) of L2/3 pyramidal neurons, cortical brain slices were prepared from mice engineered to lack the α1 subunit (α1−/−). </plain></SENT>
<SENT sid="165" pm="."><plain>The decay phase of α1−/− mIPSCs was prolonged in comparison to their WT counterparts, but, importantly, this occurred at all ages examined here (two-way ANOVA, age × genotype interaction, F3,139 = 5.75, p = 0.001; for post-hoc WT vs α1−/− comparisons, p &lt; 0.001 for P7 - 8, P10, P15 and P20, Fig. 5). </plain></SENT>
<SENT sid="166" pm="."><plain>However, in common with WT neurons, the α1−/− mIPSC decay phase became faster with development (p &lt; 0.001, one way ANOVA, Fig. 5; Table 2), suggesting that factors other than increased expression of α1-subunit containing GABAARs must contribute to the developmental profile. </plain></SENT>
<SENT sid="167" pm="."><plain>In agreement, and further implicating a role for neurosteroids, γ-CD treatment significantly reduced the decay time of α1−/− mIPSCs in P7 - 8, P10 and P15 α1−/− neurons, but in common with their WT counterparts, had no effect on the τw of P20 - 24 α1−/− mIPSCs (two-way ANOVA, age × treatment interaction, F3, 58 = 6.14, p = 0.001; for post-hoc control vs γ-CD comparisons, p &lt; 0.01 for α1−/− P7 - 8, P10 and P15 neurons and p &gt; 0.05 for P20-24, Fig. 6). </plain></SENT>
<SENT sid="168" pm="."><plain>Similarly, finasteride (50 μM) treatment reduced the τW of P7 - 8 α1−/− mIPSCs, but had no such effect on P20 - 24 α1−/− mIPSCs (two-way ANOVA, age × treatment interaction F2,43 = 9.87, p &lt; 0.001; for post-hoc control vs finasteride comparisons, p &lt; 0.05 for P7 – 8 and p &gt; 0.05 for P20-24; Fig. 6, Table 2). </plain></SENT>
<SENT sid="169" pm="."><plain>These observations suggest that the duration of cortical mIPSCs is influenced throughout the developmental period studied here by the expression of synaptic receptors incorporating the α1 subunit, but that changes to the expression of α1-GABAARs are not exclusively responsible for the altered mIPSC kinetics occurring within this developmental window. </plain></SENT>
<SENT sid="170" pm="."><plain>Furthermore, in common with WT, the waning of a neurosteroid tone is revealed to be an important determinant of the duration of α1−/− mIPSCs. </plain></SENT>
</text></p></sec><sec id="sec3.6"><label>3.6</label><title><text><SENT sid="171" pm="."><plain>The role of neurosteroids in mediating the developmental changes to phasic GABAergic transmission of L2/3 cortical interneurons </plain></SENT>
</text></title><p><text><SENT sid="172" pm="."><plain>We next investigated whether the developmentally regulated neurosteroid tone is specific for L2/3 pyramidal neurons, or is more generally experienced by other neuronal populations. </plain></SENT>
<SENT sid="173" pm="."><plain>To identify GABA-ergic interneurons we utilized GAD 67 GFP + mice, engineered to co-express green fluorescent protein (GFP) with the GABA-synthesising 67 kDa γ-amino decarboxylase (GAD 67) enzyme (Tamamaki et al. </plain></SENT>
<SENT sid="174" pm="."><plain>2003). </plain></SENT>
<SENT sid="175" pm="."><plain>Co-localization studies revealed that three major interneuron classes present in mouse neocortex, (i.e. </plain></SENT>
<SENT sid="176" pm="."><plain>calretinin-, parvalbumin-, or somatostatin-expressing) are all GFP-positive (Tamamaki et al. </plain></SENT>
<SENT sid="177" pm="."><plain>2003). </plain></SENT>
<SENT sid="178" pm="."><plain>Using epifluorescence microscopy, recordings from P7 - 8 GFP expressing neurons of L2/3, revealed mIPSCs with a decay phase (τW = 11.7 ± 0.8 ms, n = 8; Fig. 7 A, B, E - see Table 3 for additional properties), which at this age is similar to that of pyramidal neurons (P7 - 8 L2/3 pyramidal τW = 12.1 ± 0.3 ms, n = 55, p &gt; 0.05, unpaired t-test), of WT mice. </plain></SENT>
<SENT sid="179" pm="."><plain>In common with cortical pyramidal neurons, the mIPSC properties of GABA-ergic interneurons changed with development (Table 3). </plain></SENT>
<SENT sid="180" pm="."><plain>In particular, P20 - 24 interneuron mIPSCs exhibited a much reduced decay time (τW = 4.5 ± 0.3 ms, n = 14, p &lt; 0.001, unpaired t-test, Fig. 7 C, D, E, Table 3), compared to their younger counterparts. </plain></SENT>
</text></p><p><text><SENT sid="181" pm="."><plain>For P7 - 8 GABA-ergic interneurons, intracellular γ-CD (0.5 mM) had no effect on either the mIPSC peak amplitude, rise time, or frequency (in all cases p &gt; 0.05 vs control, unpaired t-test), but greatly reduced their decay time (P7 - 8 τW control = 11.7 ± 0.8 ms, n = 8, τW ICS γ-CD = 7.6 ± 0.2 ms, n = 8, p &lt; 0.001, unpaired t-test, Fig. 7 A, B, E, Table 3). </plain></SENT>
<SENT sid="182" pm="."><plain>However, the effect of intracellular γ-CD was significantly influenced by developmental stage (two-way ANOVA, age × treatment interaction, F1,33 = 16.23, p &lt; 0.001), such that the mIPSC decay of P20 - 24 interneurons was no longer influenced by the steroid scavenger (τW control = 4.5 ± 0.3 ms, n = 14; ICS γ-CD τW = 4.0 ± 0.4, n = 7, p &gt; 0.05, unpaired t-test, Fig. 7 C, D, E, Table 3). </plain></SENT>
<SENT sid="183" pm="."><plain>Therefore, phasic inhibition of L2/3 interneurons, in common with pyramidal neurons, changes with development. </plain></SENT>
<SENT sid="184" pm="."><plain>Furthermore, early in development a neurosteroid tone is experienced by the synaptic GABAARs of both GABA-ergic interneurons and principal neurons, which by P20 - 24 dissipates, resulting in brief phasic inhibitory events. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="sec4"><label>4</label><title><text><SENT sid="185" pm="."><plain>Discussion </plain></SENT>
</text></title><sec id="sec4.1"><label>4.1</label><title><text><SENT sid="186" pm="."><plain>Endogenous neurosteroids prolong the mIPSCs of cortical L2/3 neurons during development </plain></SENT>
</text></title><p><text><SENT sid="187" pm="."><plain>Postnatal development is marked by periods of considerable plasticity within cortical circuitry, wherein GABAergic neurotransmission is driven towards rapid and effective phasic inhibition, capable of supporting the complexity of mature cortical processing. </plain></SENT>
<SENT sid="188" pm="."><plain>During this period, several mechanisms may contribute to the mIPSC decay time, including: alterations in the subunit composition of synaptic GABAARs (Takahashi, 2005, Eyre et al., 2012), post-translational modifications of synaptic proteins (Vithlani et al. </plain></SENT>
<SENT sid="189" pm="."><plain>2011), the extent of receptor clustering (Petrini et al. </plain></SENT>
<SENT sid="190" pm="."><plain>2003), changes in the kinetics of GABA release and alterations to GABA uptake (Mozrzymas, 2004). </plain></SENT>
<SENT sid="191" pm="."><plain>The latter is influenced by the activity and location of the various GABA transporters. </plain></SENT>
<SENT sid="192" pm="."><plain>However, whereas the effects of transporter inhibitors on the time course of responses to iontophoretically applied GABA, or on IPSCs evoked by repetitive nerve stimulation are quite evident, they have relatively little effect on the amplitude or kinetics of mIPSCs (Keros and Hablitz, 2005, Scimemi, 2014). </plain></SENT>
<SENT sid="193" pm="."><plain>Our results indicate that in addition to a possible involvement of such factors, during postnatal development the mIPSCs of L2/3 pyramidal neurons become reduced in duration, at least in part due to a programmed loss of the influence of endogenous neurosteroids upon synaptic GABAARs. </plain></SENT>
<SENT sid="194" pm="."><plain>The validity of our conclusions is partly dependent on the specificity of γ-CD in sequestering neurosteroids. </plain></SENT>
<SENT sid="195" pm="."><plain>A previous study reported that β-CD (0.5–1.5 mM), when applied to hippocampal neurons prolonged the decay of macroscopic currents mediated by GABAARs (Pytel et al. </plain></SENT>
<SENT sid="196" pm="."><plain>2006). </plain></SENT>
<SENT sid="197" pm="."><plain>However, γ-CD treatment of thalamic VB neurons, cortical L2/3 interneurons and pyramidal cells induced a marked reduction in the mIPSC decay time early in development, but had no effect on this parameter at later developmental time-points (e.g. P20-24; Brown et al., 2015). </plain></SENT>
<SENT sid="198" pm="."><plain>Furthermore, pre-incubation with α-CD had no effect on any of the mIPSC properties at any age studied here and most importantly the effects of γ-CD on P7-8 neurons were recapitulated by pre-incubation with the 5α−R inhibitor finasteride. </plain></SENT>
<SENT sid="199" pm="."><plain>A parsimonious explanation for the decreased duration of immature L2/3 mIPSCs following γ-CD treatment posits that the steroid-sequestering molecule is effective in forming inclusion complexes with endogenous neurosteroids, whereas the observed insensitivity to α-CD reflects the hydrophobic inner cavity being too small to accommodate steroids (Szejtli, 1998, Shu et al., 2004, Brown et al., 2015). </plain></SENT>
</text></p><p><text><SENT sid="200" pm="."><plain>Theoretically, the loss of neurosteroid influence on phasic inhibition with development may result from the synaptic GABAARs becoming insensitive to this endogenous modulator (Koksma et al. </plain></SENT>
<SENT sid="201" pm="."><plain>2003). </plain></SENT>
<SENT sid="202" pm="."><plain>However, acute application of 5α3α (1 μM) clearly prolonged mIPSCs recorded from P20-24 cortical L2/3 pyramidal neurons. </plain></SENT>
<SENT sid="203" pm="."><plain>Furthermore by pre-incubating the tissue with a lower, aqueous concentration (100 nM) of 5α3α, we demonstrated these synaptic GABAARs to be highly sensitive to the neurosteroid at this stage of development. </plain></SENT>
<SENT sid="204" pm="."><plain>Alternatively, a change in steroid enzyme expression, or a lack of steroid substrate(s) may be implicated in this developmental plasticity. </plain></SENT>
<SENT sid="205" pm="."><plain>We previously demonstrated that incubation of mouse thalamic slices with 5α-DHP, the immediate precursor of 5α3α, greatly increased the duration of the mIPSCs of VB neurons (Brown et al. </plain></SENT>
<SENT sid="206" pm="."><plain>2015). </plain></SENT>
<SENT sid="207" pm="."><plain>Similarly here, incubation of P20 - 24 cortical tissue with 5α-DHP greatly prolonged the mIPSCs of cortical pyramidal neurons and in common with thalamic neurons, this effect was prevented by co-incubation with the 3α-HSD inhibitor indomethacin, or reversed by intracellular γ-CD (Brown et al. </plain></SENT>
<SENT sid="208" pm="."><plain>2015). </plain></SENT>
<SENT sid="209" pm="."><plain>Collectively these results suggest that the developmental change to phasic inhibition of cortical pyramidal neurons occurring between P7 and P20 results in a part from a lack of steroid substrate. </plain></SENT>
</text></p></sec><sec id="sec4.2"><label>4.2</label><title><text><SENT sid="210" pm="."><plain>Location of neurosteroid synthesis and action </plain></SENT>
</text></title><p><text><SENT sid="211" pm="."><plain>Previous histochemical studies support the concept of a local neurosteroid synthesis in cortex. </plain></SENT>
<SENT sid="212" pm="."><plain>In mouse cortex the staining for mRNA encoding for the 5α3α synthesising enzymes 5α-reductase Type I (5α-R I) and 3α-hydroxysteroid dehydrogenase (3α-HSD), was co-located in layer 2/3/5 pyramidal neurons (Agis-Balboa et al. </plain></SENT>
<SENT sid="213" pm="."><plain>2006). </plain></SENT>
<SENT sid="214" pm="."><plain>The 5α-R I staining co-localised with that for the vesicular glutamate transporter (VGLUT1), a marker of glutamatergic neurons (Agis-Balboa et al. </plain></SENT>
<SENT sid="215" pm="."><plain>2006). </plain></SENT>
<SENT sid="216" pm="."><plain>By contrast, the 5α-R I, or the 3α-HSD staining did not co-localize with a marker for GABA-ergic neurons, or for glia (Agis-Balboa et al. </plain></SENT>
<SENT sid="217" pm="."><plain>2006). </plain></SENT>
<SENT sid="218" pm="."><plain>In apparent agreement, an antibody raised against 5α3α revealed staining for this GABAAR-active steroid in rat cortical L2-6 pyramidal neurons, but not in cells that had the appearance of GABA-ergic interneurons, or glia, but note were not categorically identified by specific neurochemical markers of interneuron subtypes (Saalmann et al. </plain></SENT>
<SENT sid="219" pm="."><plain>2007). </plain></SENT>
<SENT sid="220" pm="."><plain>However, a recent study identified expression of 5αR Type II in cortical GABAergic cells, suggesting that neurosteroid synthesis and action may not always be confined to principal excitatory neurons (Castelli et al. </plain></SENT>
<SENT sid="221" pm="."><plain>2013). </plain></SENT>
</text></p><p><text><SENT sid="222" pm="."><plain>Whether cortical principal cells or interneuron populations are the locus of neurosteroid synthesis is not directly addressed by our finasteride, or intracellular γ-CD experiments. </plain></SENT>
<SENT sid="223" pm="."><plain>If at P7 - 8 the mode of neurosteroid action is exclusively autocrine, then a ubiquitous expression of steroid-synthesizing enzymes across different neuronal populations would be required. </plain></SENT>
<SENT sid="224" pm="."><plain>Alternatively, the local steroid concentration present during neonatal development may be sufficient to impact upon GABA-ergic and/or principal neurons, which are incapable of neurosteroid synthesis, thereby inferring a paracrine mode of action. </plain></SENT>
<SENT sid="225" pm="."><plain>Clearly, further studies are required to clarify the relative contribution of autocrine and paracrine neurosteroids to the inhibitory plasticity of the developing cortex. </plain></SENT>
</text></p><p><text><SENT sid="226" pm="."><plain>Irrespective of the locus of synthesis, the lipophilic steroid is considered to access the synaptic GABAARs by lateral diffusion via the plasma membrane, a mechanism congruent with the proposed transmembrane neurosteroid binding site on the receptor (Hosie et al., 2006, Chisari et al., 2010). </plain></SENT>
<SENT sid="227" pm="."><plain>Numerous in vitro electrophysiological studies report enhancement of GABAAR function by low nM aqueous concentrations of 5α3α (see Belelli and Lambert, 2005), advocating the presence of a relatively high affinity binding site on the GABAAR. </plain></SENT>
<SENT sid="228" pm="."><plain>However, such neurosteroids are highly lipophilic, permitting much greater local concentrations to accumulate in the vicinity of the receptor, obviating the requirement for a high affinity binding site. </plain></SENT>
<SENT sid="229" pm="."><plain>Indeed, the proposed low affinity binding site (Chisari et al. </plain></SENT>
<SENT sid="230" pm="."><plain>2010) is consistent with our observation that even when γ-CD was applied exclusively to the cytosolic compartment, it efficiently removed the neurosteroid influence on synaptic GABAARs of immature cortical pyramidal neurons. </plain></SENT>
</text></p></sec><sec id="sec4.3"><label>4.3</label><title><text><SENT sid="231" pm="."><plain>The role of GABAAR subunit composition in developmental plasticity of phasic GABAergic neurotransmission </plain></SENT>
</text></title><p><text><SENT sid="232" pm="."><plain>The α1 subunit mRNA and protein is present in the cortex early in development, albeit at low levels, whereas the converse is true for α2/3 subunits, which are highly expressed early in life, before they decrease to lower levels in the mature cortex (Laurie et al., 1992, Fritschy et al., 1994, Pirker et al., 2000). </plain></SENT>
<SENT sid="233" pm="."><plain>Here the mIPSCs obtained from α1−/− L2/3 pyramidal neurons at P7 - 8, P10, P15 and P20 - 24 exhibited slower decay kinetics c.f. WT controls at each developmental time-point. </plain></SENT>
<SENT sid="234" pm="."><plain>Since α1-GABAARs are associated with fast decay kinetics (Picton and Fisher, 2007), this finding suggests that a proportion of synaptic α1-GABAARs are present even at P7 - 8 in L2/3 pyramidal neurons. </plain></SENT>
<SENT sid="235" pm="."><plain>However, a developmental decrease of the mIPSC decay time of α1−/− L2/3 pyramidal neurons was still evident, implying the presence of additional factors, as previously suggested (Bosman et al. </plain></SENT>
<SENT sid="236" pm="."><plain>2005). </plain></SENT>
<SENT sid="237" pm="."><plain>Moreover, the developmental profile of γ-CD sensitivity for mIPSCs from P7 - 8, P10 and P15 α1−/− L2/3 pyramidal neurons was indistinguishable to WT. </plain></SENT>
<SENT sid="238" pm="."><plain>In summary, these findings indicate that although the duration of the mIPSCs is influenced by the α1 subunit, it is not solely responsible for the developmental changes that occur in the postnatal period P7 – 20. </plain></SENT>
<SENT sid="239" pm="."><plain>The results presented here reveal the waning impact during development of the endogenous neurosteroid tone is an additional important factor in influencing phasic GABAergic neurotransmission of both WT and α1−/− L2/3 pyramidal neurons. </plain></SENT>
<SENT sid="240" pm="."><plain>However, a comparison of the mIPSC decay of P7 - 8 and P20 - 24 α1−/− neurons, when treated with either finasteride, or γ-CD, reveals an additional, as yet unidentified factor(s) that influences phasic GABAergic neurotransmission during postnatal development. </plain></SENT>
</text></p></sec><sec id="sec4.4"><label>4.4</label><title><text><SENT sid="241" pm="."><plain>The physiological role of GABAAR-active neurosteroids during development </plain></SENT>
</text></title><p><text><SENT sid="242" pm="."><plain>This study focused on L2/3 cortical neurons and found that the synaptic GABAARs expressed on both pyramidal and interneuron populations are developmentally influenced by neurosteroids to modulate the duration of GABAergic synaptic transmission. </plain></SENT>
<SENT sid="243" pm="."><plain>These changes in neurosteroid influence are occurring during an intense period of synaptogenesis, which may be reflected by our observation that the frequency of mIPSCs increases during postnatal development. </plain></SENT>
<SENT sid="244" pm="."><plain>Furthermore, at this time GABA may exert a depolarizing effect due to the dominance of the chloride importer NKCC1 (Owens et al., 1996, Ben-Ari et al., 2007). </plain></SENT>
<SENT sid="245" pm="."><plain>Hence, long duration synaptic events may be suited to recruiting voltage-gated calcium channel activation, which in turn may initiate various Ca2+-dependent processes in the neuron. </plain></SENT>
<SENT sid="246" pm="."><plain>In this scenario, the emergence of mature (hyperpolarizing) GABA-ergic signalling would inversely correlate with the decline of neurosteroid production. </plain></SENT>
<SENT sid="247" pm="."><plain>Adding complexity, a recent report has demonstrated that neonatal administration of 5α3α influences the hippocampal expression of the K+ Cl− co-transporter KCC2 (Modol et al., 2014). </plain></SENT>
</text></p><p><text><SENT sid="248" pm="."><plain>We recently reported a similar developmentally controlled neurosteroid tone in somatosensory thalamocortical neurons (Brown et al. </plain></SENT>
<SENT sid="249" pm="."><plain>2015). </plain></SENT>
<SENT sid="250" pm="."><plain>During development, the window of neurosteroid influence on GABA-ergic transmission in the somatosensory thalamus is shorter than that described here for cortex. </plain></SENT>
<SENT sid="251" pm="."><plain>In thalamic neurons the neurosteroid tone was absent by P10 (Brown et al. </plain></SENT>
<SENT sid="252" pm="."><plain>2015), whereas in cortex this form of endogenous modulation persisted through to P15, but was no longer present by P20 - 24. </plain></SENT>
<SENT sid="253" pm="."><plain>The reasons for the distinct temporal regulation between thalamus and cortex are unknown. </plain></SENT>
<SENT sid="254" pm="."><plain>In addition to thalamus and cortex, previous studies have identified a similar neurosteroid tone in spinal neurons of the dorsal horn (Keller et al. </plain></SENT>
<SENT sid="255" pm="."><plain>2004), which also exhibits a differential developmental profile for lamina II and lamina III/IV neurons (Inquimbert et al. </plain></SENT>
<SENT sid="256" pm="."><plain>2008). </plain></SENT>
<SENT sid="257" pm="."><plain>Hence, the existence of a neurosteroid tone at multiple tiers of the CNS suggests a widespread role during postnatal development. </plain></SENT>
<SENT sid="258" pm="."><plain>Deciphering the interplay between endogenous neurosteroid synthesis, GABAAR potentiation, and neuronal maturation should therefore be a focus for future studies. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="bib1"><text><SENT sid="259" pm="."><plain>Agis-BalboaR.C.PinnaG.ZhubiA.MalokuE.VeldicM.CostaE.GuidottiA.Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesisProc. </plain></SENT>
<SENT sid="260" pm="."><plain>Natl. </plain></SENT>
<SENT sid="261" pm="."><plain>Acad. </plain></SENT>
<SENT sid="262" pm="."><plain>Sci. </plain></SENT>
<SENT sid="263" pm="."><plain>U. </plain></SENT>
<SENT sid="264" pm="."><plain>S. </plain></SENT>
<SENT sid="265" pm="."><plain>A.1032006146021460716984997 </plain></SENT>
</text></ref><ref id="bib2"><text><SENT sid="266" pm="."><plain>BelelliD.LambertJ.J.Neurosteroids: endogenous regulators of the GABA(A) receptorNat. </plain></SENT>
<SENT sid="267" pm="."><plain>Rev. </plain></SENT>
<SENT sid="268" pm="."><plain>Neurosci.6200556557515959466 </plain></SENT>
</text></ref><ref id="bib3"><text><SENT sid="269" pm="."><plain>Ben-AriY.GaiarsaJ.L.TyzioR.KhazipovR.GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillationsPhysiol. </plain></SENT>
<SENT sid="270" pm="."><plain>Rev.8720071215128417928584 </plain></SENT>
</text></ref><ref id="bib4"><text><SENT sid="271" pm="."><plain>BenkwitzC.LiaoM.LasterM.J.SonnerJ.M.EgerE.I.2ndPearceR.A.Determination of the EC50 amnesic concentration of etomidate and its diffusion profile in brain tissue: implications for in vitro studiesAnesthesiology106200711412317197853 </plain></SENT>
</text></ref><ref id="bib5"><text><SENT sid="272" pm="."><plain>BosmanL.W.HeinenK.SpijkerS.BrussaardA.B.Mice lacking the major adult GABAA receptor subtype have normal number of synapses, but retain juvenile IPSC kinetics until adulthoodJ. Neurophysiol.94200533834615758057 </plain></SENT>
</text></ref><ref id="bib6"><text><SENT sid="273" pm="."><plain>BrickleyS.G.Cull-CandyS.G.FarrantM.Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptorsJ. Physiol.497Pt 319967537599003560 </plain></SENT>
</text></ref><ref id="bib7"><text><SENT sid="274" pm="."><plain>BrownA.R.HerdM.B.BelelliD.LambertJ.J.Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neuronesJ. Physiol.593201526728425556800 </plain></SENT>
</text></ref><ref id="bib8"><text><SENT sid="275" pm="."><plain>CastelliM.P.CastiA.CasuA.FrauR.BortolatoM.SpigaS.EnnasM.G.Regional distribution of 5alpha-reductase type 2 in the adult rat brain: an immunohistochemical analysisPsychoneuroendocrinology38201328129322776423 </plain></SENT>
</text></ref><ref id="bib9"><text><SENT sid="276" pm="."><plain>ChisariM.EisenmanL.N.CoveyD.F.MennerickS.ZorumskiC.F.The sticky issue of neurosteroids and GABA(A) receptorsTrends Neurosci.33201029930620409596 </plain></SENT>
</text></ref><ref id="bib10"><text><SENT sid="277" pm="."><plain>DavisM.E.BrewsterM.E.Cyclodextrin-based pharmaceutics: past, present and futureNat. </plain></SENT>
<SENT sid="278" pm="."><plain>Rev. </plain></SENT>
<SENT sid="279" pm="."><plain>Drug Discov.320041023103515573101 </plain></SENT>
</text></ref><ref id="bib11"><text><SENT sid="280" pm="."><plain>DeiddaG.BozarthI.F.CanceddaL.Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectivesFront. </plain></SENT>
<SENT sid="281" pm="."><plain>Cell Neurosci.8201411924904277 </plain></SENT>
</text></ref><ref id="bib12"><text><SENT sid="282" pm="."><plain>Do RegoJ.L.SeongJ.Y.BurelD.LeprinceJ.Luu-TheV.TsutsuiK.TononM.C.PelletierG.VaudryH.Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptidesFront. </plain></SENT>
<SENT sid="283" pm="."><plain>Neuroendocrinol.30200925930119505496 </plain></SENT>
</text></ref><ref id="bib13"><text><SENT sid="284" pm="."><plain>DunningD.D.HooverC.L.SolteszI.SmithM.A.O'DowdD.K.GABA(A) receptor-mediated miniature postsynaptic currents and alpha-subunit expression in developing cortical neuronsJ. Neurophysiol.8219993286329710601460 </plain></SENT>
</text></ref><ref id="bib14"><text><SENT sid="285" pm="."><plain>EyreM.D.RenziM.FarrantM.NusserZ.Setting the time course of inhibitory synaptic currents by mixing multiple GABA(A) receptor alpha subunit isoformsJ. Neurosci.3220125853586722539847 </plain></SENT>
</text></ref><ref id="bib16"><text><SENT sid="286" pm="."><plain>FritschyJ.M.PanzanelliP.GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous systemEur. </plain></SENT>
<SENT sid="287" pm="."><plain>J. </plain></SENT>
<SENT sid="288" pm="."><plain>Neurosci.3920141845186524628861 </plain></SENT>
</text></ref><ref id="bib17"><text><SENT sid="289" pm="."><plain>FritschyJ.M.PaysanJ.EnnaA.MohlerH.Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical studyJ. Neurosci.141994530253248083738 </plain></SENT>
</text></ref><ref id="bib18"><text><SENT sid="290" pm="."><plain>GoldsteinP.A.ElsenF.P.YingS.W.FergusonC.HomanicsG.E.HarrisonN.L.Prolongation of hippocampal miniature inhibitory postsynaptic currents in mice lacking the GABA(A) receptor alpha1 subunitJ. Neurophysiol.8820023208321712466441 </plain></SENT>
</text></ref><ref id="bib19"><text><SENT sid="291" pm="."><plain>GredellJ.A.TurnquistP.A.MaciverM.B.PearceR.A.Determination of diffusion and partition coefficients of propofol in rat brain tissue: implications for studies of drug action in vitroBr. </plain></SENT>
<SENT sid="292" pm="."><plain>J. </plain></SENT>
<SENT sid="293" pm="."><plain>Anaesth.93200481081715377586 </plain></SENT>
</text></ref><ref id="bib20"><text><SENT sid="294" pm="."><plain>GrobinA.C.MorrowA.L.3Alpha-hydroxy-5alpha-pregnan-20-one levels and GABA(A) receptor-mediated 36Cl(-) flux across development in rat cerebral cortexBrain Res. </plain></SENT>
<SENT sid="295" pm="."><plain>Dev. </plain></SENT>
<SENT sid="296" pm="."><plain>Brain Res.1312001313911718833 </plain></SENT>
</text></ref><ref id="bib21"><text><SENT sid="297" pm="."><plain>HollrigelG.S.SolteszI.Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrusJ. Neurosci.171997511951289185549 </plain></SENT>
</text></ref><ref id="bib22"><text><SENT sid="298" pm="."><plain>HosieA.M.WilkinsM.E.da SilvaH.M.SmartT.G.Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sitesNature444200648648917108970 </plain></SENT>
</text></ref><ref id="bib23"><text><SENT sid="299" pm="."><plain>InquimbertP.RodeauJ.L.SchlichterR.Regional differences in the decay kinetics of GABA(A) receptor-mediated miniature IPSCs in the dorsal horn of the rat spinal cord are determined by mitochondrial transport of cholesterolJ. Neurosci.2820083427343718367609 </plain></SENT>
</text></ref><ref id="bib24"><text><SENT sid="300" pm="."><plain>JuttnerR.MeierJ.GrantynR.Slow IPSC kinetics, low levels of alpha1 subunit expression and paired-pulse depression are distinct properties of neonatal inhibitory GABAergic synaptic connections in the mouse superior colliculusEur. </plain></SENT>
<SENT sid="301" pm="."><plain>J. </plain></SENT>
<SENT sid="302" pm="."><plain>Neurosci.1320012088209811422449 </plain></SENT>
</text></ref><ref id="bib25"><text><SENT sid="303" pm="."><plain>KapurJ.MacdonaldR.L.Postnatal development of hippocampal dentate granule cell gamma-aminobutyric acidA receptor pharmacological propertiesMol. </plain></SENT>
<SENT sid="304" pm="."><plain>Pharmacol.55199944445210051527 </plain></SENT>
</text></ref><ref id="bib26"><text><SENT sid="305" pm="."><plain>KellerA.F.BretonJ.D.SchlichterR.PoisbeauP.Production of 5alpha-reduced neurosteroids is developmentally regulated and shapes GABA(A) miniature IPSCs in lamina II of the spinal cordJ. Neurosci.24200490791514749435 </plain></SENT>
</text></ref><ref id="bib27"><text><SENT sid="306" pm="."><plain>KerosS.HablitzJ.J.Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABAA conductances in rat neocortexJ. Neurophysiol.94320052073208515987761 </plain></SENT>
</text></ref><ref id="bib28"><text><SENT sid="307" pm="."><plain>KoksmaJ.J.Van KesterenR.E.RosahlT.W.ZwartR.SmitA.B.LuddensH.BrussaardA.B.Oxytocin regulates neurosteroid modulation of GABAA receptors in supraoptic nucleus around parturitionJ. Neurosci.23200378879712574407 </plain></SENT>
</text></ref><ref id="bib29"><text><SENT sid="308" pm="."><plain>LaurieD.J.WisdenW.SeeburgP.H.The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. </plain></SENT>
<SENT sid="309" pm="."><plain>III. </plain></SENT>
<SENT sid="310" pm="."><plain>Embryonic and postnatal developmentJ. Neurosci.121992415141721331359 </plain></SENT>
</text></ref><ref id="bib30"><text><SENT sid="311" pm="."><plain>ModolL.CasasC.LlidoA.NavarroX.PallaresM.DarbraS.Neonatal allopregnanolone or finasteride administration modifies hippocampal K+ Cl- co-transporter expression during early development in male ratsJ. Steroid Biochem. </plain></SENT>
<SENT sid="312" pm="."><plain>Mol. </plain></SENT>
<SENT sid="313" pm="."><plain>Biol.143201434334724861264 </plain></SENT>
</text></ref><ref id="bib31"><text><SENT sid="314" pm="."><plain>MozrzymasJ.W.Dynamism of GABAA receptor activation shapes the “personality” of inhibitory synapsesNeuropharmacology47200494596015555630 </plain></SENT>
</text></ref><ref id="bib32"><text><SENT sid="315" pm="."><plain>OkadaM.OnoderaK.Van RenterghemC.SieghartW.TakahashiT.Functional correlation of GABA(A) receptor alpha subunits expression with the properties of IPSCs in the developing thalamusJ. Neurosci.2020002202220810704495 </plain></SENT>
</text></ref><ref id="bib33"><text><SENT sid="316" pm="."><plain>OlsenR.W.SieghartW.International Union of Pharmacology. </plain></SENT>
<SENT sid="317" pm="."><plain>LXX. </plain></SENT>
<SENT sid="318" pm="."><plain>Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. </plain></SENT>
<SENT sid="319" pm="."><plain>UpdatePharmacol. </plain></SENT>
<SENT sid="320" pm="."><plain>Rev.60200824326018790874 </plain></SENT>
</text></ref><ref id="bib34"><text><SENT sid="321" pm="."><plain>OrtinskiP.I.LuC.TakagakiK.FuZ.ViciniS.Expression of distinct alpha subunits of GABAA receptor regulates inhibitory synaptic strengthJ. Neurophysiol.9220041718172715102896 </plain></SENT>
</text></ref><ref id="bib35"><text><SENT sid="322" pm="."><plain>OwensD.F.BoyceL.H.DavisM.B.KriegsteinA.R.Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imagingJ. Neurosci.161996641464238815920 </plain></SENT>
</text></ref><ref id="bib36"><text><SENT sid="323" pm="."><plain>PedenD.R.PetitjeanC.M.HerdM.B.DurakoglugilM.S.RosahlT.W.WaffordK.HomanicsG.E.BelelliD.FritschyJ.M.LambertJ.J.Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neuronesJ. Physiol.586200896598718063661 </plain></SENT>
</text></ref><ref id="bib37"><text><SENT sid="324" pm="."><plain>PetriniE.M.ZacchiP.BarberisA.MozrzymasJ.W.CherubiniE.Declusterization of GABAA receptors affects the kinetic properties of GABAergic currents in cultured hippocampal neuronsJ. Biol. </plain></SENT>
<SENT sid="325" pm="."><plain>Chem.2782003162711627912600990 </plain></SENT>
</text></ref><ref id="bib38"><text><SENT sid="326" pm="."><plain>PictonA.J.FisherJ.L.Effect of the alpha subunit subtype on the macroscopic kinetic properties of recombinant GABA(A) receptorsBrain Res.11652007404917658489 </plain></SENT>
</text></ref><ref id="bib39"><text><SENT sid="327" pm="."><plain>PirkerS.SchwarzerC.WieselthalerA.SieghartW.SperkG.GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brainNeuroscience101200081585011113332 </plain></SENT>
</text></ref><ref id="bib40"><text><SENT sid="328" pm="."><plain>PistisM.BelelliD.PetersJ.A.LambertJ.J.The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative studyBr. </plain></SENT>
<SENT sid="329" pm="."><plain>J. </plain></SENT>
<SENT sid="330" pm="."><plain>Pharmacol.1221997170717199422818 </plain></SENT>
</text></ref><ref id="bib41"><text><SENT sid="331" pm="."><plain>PytelM.MercikK.MozrzymasJ.W.Interaction between cyclodextrin and neuronal membrane results in modulation of GABA(A) receptor conformational transitionsBr. </plain></SENT>
<SENT sid="332" pm="."><plain>J. </plain></SENT>
<SENT sid="333" pm="."><plain>Pharmacol.148200641342216702996 </plain></SENT>
</text></ref><ref id="bib42"><text><SENT sid="334" pm="."><plain>RoviraC.Ben-AriY.Developmental study of benzodiazepine effects on monosynaptic GABAA-mediated IPSPs of rat hippocampal neuronsJ. Neurophysiol.701993107610857901345 </plain></SENT>
</text></ref><ref id="bib43"><text><SENT sid="335" pm="."><plain>RudolphU.MohlerH.GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autismAnnu. </plain></SENT>
<SENT sid="336" pm="."><plain>Rev. </plain></SENT>
<SENT sid="337" pm="."><plain>Pharmacol. </plain></SENT>
<SENT sid="338" pm="."><plain>Toxicol.54201448350724160694 </plain></SENT>
</text></ref><ref id="bib44"><text><SENT sid="339" pm="."><plain>SaalmannY.B.KirkcaldieM.T.WaldronS.CalfordM.B.Cellular distribution of the GABAA receptor-modulating 3alpha-hydroxy, 5alpha-reduced pregnane steroids in the adult rat brainJ. Neuroendocrinol.19200727228417355317 </plain></SENT>
</text></ref><ref id="bib45"><text><SENT sid="340" pm="."><plain>ScimemiA.Structure, function and plasticity of GABA transportersFront. </plain></SENT>
<SENT sid="341" pm="."><plain>Cell Neurosci.8201411424478626 </plain></SENT>
</text></ref><ref id="bib46"><text><SENT sid="342" pm="."><plain>ShuH.J.EisenmanL.N.JinadasaD.CoveyD.F.ZorumskiC.F.MennerickS.Slow actions of neuroactive steroids at GABAA receptorsJ. Neurosci.2420046667667515282269 </plain></SENT>
</text></ref><ref id="bib47"><text><SENT sid="343" pm="."><plain>ShuH.J.ZengC.M.WangC.CoveyD.F.ZorumskiC.F.MennerickS.Cyclodextrins sequester neuroactive steroids and differentiate mechanisms that rate limit steroid actionsBr. </plain></SENT>
<SENT sid="344" pm="."><plain>J. </plain></SENT>
<SENT sid="345" pm="."><plain>Pharmacol.150200716417517160009 </plain></SENT>
</text></ref><ref id="bib48"><text><SENT sid="346" pm="."><plain>SurC.WaffordK.A.ReynoldsD.S.HadinghamK.L.BromidgeF.MacaulayA.CollinsonN.O'MearaG.HowellO.NewmanR.MyersJ.AtackJ.R.DawsonG.R.McKernanR.M.WhitingP.J.RosahlT.W.Loss of the major GABA(A) receptor subtype in the brain is not lethal in miceJ. Neurosci.2120013409341811331371 </plain></SENT>
</text></ref><ref id="bib49"><text><SENT sid="347" pm="."><plain>SzejtliJ.Introduction and general overview of cyclodextrin chemistryChem. </plain></SENT>
<SENT sid="348" pm="."><plain>Rev.9819981743175411848947 </plain></SENT>
</text></ref><ref id="bib50"><text><SENT sid="349" pm="."><plain>TakahashiT.Postsynaptic receptor mechanisms underlying developmental speeding of synaptic transmissionNeurosci. </plain></SENT>
<SENT sid="350" pm="."><plain>Res.53200522924016219377 </plain></SENT>
</text></ref><ref id="bib51"><text><SENT sid="351" pm="."><plain>TamamakiN.YanagawaY.TomiokaR.MiyazakiJ.ObataK.KanekoT.Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouseJ. Comp. </plain></SENT>
<SENT sid="352" pm="."><plain>Neurol.4672003607914574680 </plain></SENT>
</text></ref><ref id="bib52"><text><SENT sid="353" pm="."><plain>TiaS.WangJ.F.KotchabhakdiN.ViciniS.Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABA(A) receptor alpha 6 subunitJ. Neurosci.161996363036408642407 </plain></SENT>
</text></ref><ref id="bib54"><text><SENT sid="354" pm="."><plain>ViciniS.New perspectives in the functional role of GABA(A) channel heterogeneityMol. </plain></SENT>
<SENT sid="355" pm="."><plain>Neurobiol.1919999711010371465 </plain></SENT>
</text></ref><ref id="bib55"><text><SENT sid="356" pm="."><plain>ViciniS.FergusonC.PrybylowskiK.KralicJ.MorrowA.L.HomanicsG.E.GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neuronsJ. Neurosci.2120013009301611312285 </plain></SENT>
</text></ref><ref id="bib56"><text><SENT sid="357" pm="."><plain>VithlaniM.TerunumaM.MossS.J.The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapsesPhysiol. </plain></SENT>
<SENT sid="358" pm="."><plain>Rev.9120111009102221742794 </plain></SENT>
</text></ref><ref id="bib57"><text><SENT sid="359" pm="."><plain>WhittingtonM.A.CunninghamM.O.LeBeauF.E.RaccaC.TraubR.D.Multiple origins of the cortical gamma rhythmDev. </plain></SENT>
<SENT sid="360" pm="."><plain>Neurobiol.7120119210621154913 </plain></SENT>
</text></ref><ref id="bib58"><text><SENT sid="361" pm="."><plain>ZorumskiC.F.PaulS.M.IzumiY.CoveyD.F.MennerickS.Neurosteroids, stress and depression: potential therapeutic opportunitiesNeurosci. </plain></SENT>
<SENT sid="362" pm="."><plain>Biobehav Rev.37201310912223085210 </plain></SENT>
</text></ref></ref-list></SecTag><SecTag type="ACK_FUND"><ack id="ack0010"><title>Acknowledgements</title><p><text4fund><text><SENT sid="363" pm="."><plain>This work was supported by an AJ Clark Studentship (British Pharmacological Society) to support ARB and an MRC studentship supported SJM. </plain></SENT>
<SENT sid="364" pm="."><plain>The funding sources had no involvement in the study design; the collection, analysis and interpretation of the data; in the writing of the report; or in the decision to submit the article for publication. </plain></SENT>
<SENT sid="365" pm="."><plain>We thank Dr. Rosahl for providing the α1−/− mice; Professor Yanagawa for permission to use the GAD67-GFP mice that were provided to us by Professor Parnavelas and to Dr. Dempster for providing the electrophysiological analysis software. </plain></SENT>
</text></text4fund></p></ack></SecTag></back><floats-group><SecTag type="FIG"><fig id="fig1"><label>Fig. 1</label><caption><p><text><SENT sid="366" pm="."><plain>The properties of mIPSCs recorded from WT L2/3 pyramidal neurons during postnatal development. </plain></SENT>
<SENT sid="367" pm="."><plain>A). </plain></SENT>
<SENT sid="368" pm="."><plain>Traces showing typical current recordings from L2/3 pyramidal neurons derived from WT mice at P7 (top), P10 (middle) and P20 (bottom). </plain></SENT>
<SENT sid="369" pm="."><plain>Note the increase in the frequency of synaptic events with development. B). </plain></SENT>
<SENT sid="370" pm="."><plain>Averaged, superimposed mIPSCs normalised with respect to peak amplitude, recorded from representative WT L2/3 pyramidal neurons of P7, P10, P15 and P20 mice. </plain></SENT>
<SENT sid="371" pm="."><plain>The decay time decreases progressively with development. C). </plain></SENT>
<SENT sid="372" pm="."><plain>A graph showing both the net decrease in τW, and the concomitant increase in mIPSC frequency (n = 14–55 neurons) occurring with development. </plain></SENT>
<SENT sid="373" pm="."><plain>Symbols represent the mean ± S.E.M. </plain></SENT>
</text></p></caption><graphic xlink:href="gr1"/></fig></SecTag><SecTag type="FIG"><fig id="fig2"><label>Fig. 2</label><caption><p><text><SENT sid="374" pm="."><plain>GABAergic synaptic currents of L2/3 pyramidal neurons are influenced by an endogenous neurosteroid tone during early postnatal development. </plain></SENT>
<SENT sid="375" pm="."><plain>A - E). </plain></SENT>
<SENT sid="376" pm="."><plain>Averaged mIPSCs, superimposed and normalised with respect to peak amplitude from a representative P7 cortical pyramidal neuron during control conditions (black line) and following treatment (grey lines) with either, A) 1 mM γ-CD, B) 1 mM α-CD, C) 50 μM finasteride (Fin), D) 0.5 mM γ-CD in the ICS only, or E) 50 μM finasteride + 0.5 mM γ-CD in the ICS. F). </plain></SENT>
<SENT sid="377" pm="."><plain>A cumulative probability plot of the mIPSC T50 for control P7 - 8 L2/3 pyramidal neurons (events pooled from 55 cells) and P7 - 8 L2/3 pyramidal neurons following treatment conditions described above. </plain></SENT>
<SENT sid="378" pm="."><plain>All treatments apart from α-CD resulted in a significant leftward shift in the T50 distribution indicating that these treatments resulted in mIPSCs with reduced decay times compared with control (in all cases p &lt; 0.001, KS-test). G) Summary bar graph depicting the mean τw values for P7 - 8 mIPSCs for control and after cyclodextrin/finasteride treatments (n = 6–55 cells). * = p &lt; 0.05, *** = p &lt; 0.001, vs control. n.s. = not significant, one way ANOVA with Tukey post hoc test. </plain></SENT>
</text></p></caption><graphic xlink:href="gr2"/></fig></SecTag><SecTag type="FIG"><fig id="fig3"><label>Fig. 3</label><caption><p><text><SENT sid="379" pm="."><plain>The cortical neurosteroid tone is developmentally regulated. </plain></SENT>
<SENT sid="380" pm="."><plain>A bar graph showing the effect of γ-CD pre-incubation (1 mM) on the τW of mIPSCs recorded from WT L2/3 pyramidal neurons during development (n = 8–55 cells). </plain></SENT>
<SENT sid="381" pm="."><plain>Note that at P7 - 8, P10 and P15 the γ-CD pre-incubation resulted in a significant reduction in τWvs control. </plain></SENT>
<SENT sid="382" pm="."><plain>For comparison, the effect of finasteride (50 μM) preincubation at P7 - 8 and P20 - 24 is also shown (n = 6–55 cells). ††† = p &lt; 0.001, vs control, post hoc Tukey HSD test following two-way ANOVA. * = p &lt; 0.05, *** = p &lt; 0.001, vs control, post-hoc independent samples t-test following two-way ANOVA. n.s. = not significant. </plain></SENT>
<SENT sid="383" pm="."><plain>The independent variables for the two-way ANOVAs were postnatal age and treatment (γ-CD, or finasteride). </plain></SENT>
<SENT sid="384" pm="."><plain>Illustrated above each developmental time point are the corresponding averaged and superimposed mIPSCs, normalised with respect to peak amplitude, obtained from representative pyramidal neurons in the absence (control, black line) and following 1 mM γ-CD pre-incubation (grey line). </plain></SENT>
</text></p></caption><graphic xlink:href="gr3"/></fig></SecTag><SecTag type="FIG"><fig id="fig4"><label>Fig. 4</label><caption><p><text><SENT sid="385" pm="."><plain>The synaptic GABAARs of P20 – 24 L2/3 cortical pyramidal neurons are neurosteroid sensitive and furthermore, P20 – 24 cortical brain slices can synthesise GABAAR-active neurosteroids. </plain></SENT>
<SENT sid="386" pm="."><plain>A). </plain></SENT>
<SENT sid="387" pm="."><plain>Averaged, superimposed mIPSCs normalised with respect to peak amplitude, recorded from representative WT L2/3 cortical pyramidal neurons from brain slices derived from P20 - 24 mice, under control conditions and following incubation (&gt;120 min) with 100 nM 5α3α. B) Averaged, superimposed P20-24 mIPSCs normalised with respect to peak amplitude, recorded under control conditions and following incubation (&gt;120 min) with 3 μM 5α-DHP; co-incubation with 100 μM indomethacin (Indo) and 3 μM 5α-DHP (&gt;120 min); or incubation with 3 μM 5α-DHP (&gt;120 min) followed by 0.5 mM ICS γ-CD. C) Summary bar graph illustrating the increase in the mIPSC τw in response to incubation of 100 nM 5α3α; 5α-DHP incubation and the much reduced 5α-DHP effect following either co-incubation with 100 μM indomethacin (Indo), or addition of 0.5 mM γ-CD to the ICS (n = 5–25 cells). *** = p &lt; 0.001 vs control, one way ANOVA with Tukey post hoc analysis. </plain></SENT>
</text></p></caption><graphic xlink:href="gr4"/></fig></SecTag><SecTag type="FIG"><fig id="fig5"><label>Fig. 5</label><caption><p><text><SENT sid="388" pm="."><plain>The effect of α1 subunit deletion on the τWof mIPSCs recorded from L2/3 neurons during development. </plain></SENT>
<SENT sid="389" pm="."><plain>A bar graph comparing τW of mIPSCs recorded from WT and α1−/− L2/3 neurons during postnatal development (n = 4–13 α1−/− neurons). </plain></SENT>
<SENT sid="390" pm="."><plain>The WT data is adapted from Fig. 1. </plain></SENT>
<SENT sid="391" pm="."><plain>Note that the decay time of mIPSCs of both WT and α1−/− L2/3 pyramidal neurons, becomes reduced with age. </plain></SENT>
<SENT sid="392" pm="."><plain>However, at each developmental stage, mIPSCs recorded from α1−/− neurons exhibit a slower decay c.f. those recorded from equivalent WT neurons (*** = p &lt; 0.001, post-hoc independent samples t-test following two-way ANOVA, with postnatal age and genotype as the independent variables). </plain></SENT>
<SENT sid="393" pm="."><plain>Illustrated above each developmental time point are corresponding averaged and superimposed mIPSCs, normalised with respect to peak amplitude, obtained from representative WT (black line) and α1−/− pyramidal neurons (grey line). </plain></SENT>
</text></p></caption><graphic xlink:href="gr5"/></fig></SecTag><SecTag type="FIG"><fig id="fig6"><label>Fig. 6</label><caption><p><text><SENT sid="394" pm="."><plain>A developmentally-regulated neurosteroid tone influences the decay time of mIPSCs recorded from α1−/−L2/3 neurons. </plain></SENT>
<SENT sid="395" pm="."><plain>A bar graph showing the effect of γ-CD pre-incubation (1 mM) on the τW of mIPSCs recorded from α1−/− L2/3 pyramidal neurons during development (n = 4–13 cells). </plain></SENT>
<SENT sid="396" pm="."><plain>In common with WT L2/3 pyramidal neurons, treatment of α1−/− cortical brain slices with γ-CD results in faster decaying mIPSCs at P7 - 8, P10 and P15, but not at P20-24. </plain></SENT>
<SENT sid="397" pm="."><plain>For comparison, the effect of finasteride (50 μM) pre-incubation at P7 - 8 and P20 - 24 is also shown (n = 7–14 cells). †† = p &lt; 0.01, † = p &lt; 0.05 vs control, post hoc Tukey HSD test following a two-way ANOVA. ** = p &lt; 0.01, *** = p &lt; 0.001, vs control, post-hoc independent samples t-test following a two-way ANOVA. n.s. = not significant. </plain></SENT>
<SENT sid="398" pm="."><plain>The independent variables for the two-way ANOVAs were postnatal age and treatment. </plain></SENT>
<SENT sid="399" pm="."><plain>Illustrated above each developmental time point is the corresponding averaged and superimposed mIPSCs, normalised with respect to peak amplitude, obtained from representative pyramidal neurons of WT and α1−/− in the absence (control, black line) and following 1 mM γ-CD pre-incubation (grey line). </plain></SENT>
</text></p></caption><graphic xlink:href="gr6"/></fig></SecTag><SecTag type="FIG"><fig id="fig7"><label>Fig. 7</label><caption><p><text><SENT sid="400" pm="."><plain>The effect of intracellular γ-cyclodextrin (0.5 mM) on the decay kinetics of mIPSCs recorded from P7 and P20 - 24 L2/3 cortical GAD67-GFP + neurons. </plain></SENT>
<SENT sid="401" pm="."><plain>A, C). </plain></SENT>
<SENT sid="402" pm="."><plain>Superimposed, averaged mIPSCs normalised with respect to peak amplitude from representative P7 (A) and P20 (C) control L2/3 GFP + neurons (black line) and L2/3 GFP + neurons in which the intracellular solution contained 0.5 mM γ-CD (grey line) at P7 (A) and P20 (C). B, D). </plain></SENT>
<SENT sid="403" pm="."><plain>Cumulative probability plots of the mIPSC T50 for P7 (B) and P20 - 24 neurons (D) control (black line) and ICS + γ-CD (grey line). </plain></SENT>
<SENT sid="404" pm="."><plain>In each case events were pooled from n = 8 GFP + cells (P7 control), n = 8 GFP + cells (P7 ICS+ γ-CD), n = 14 GFP + cells (P20 - 24 control), and n = 7 GFP + cells (P20 - 24 ICS+ γ-CD). </plain></SENT>
<SENT sid="405" pm="."><plain>For P7, but not for P20 - 24 cells, the mIPSC T50 distribution is left-shifted indicating that all mIPSCs recorded from P7 GFP + cells treated with intracellular γ-CD, exhibited faster decay kinetics, compared with control (p &lt; 0.001, KS-test). E). </plain></SENT>
<SENT sid="406" pm="."><plain>A summary bar graph showing a significant decrease in the mIPSC τW following intracellular γ-CD treatment at P7, but not at P20 - 24. n.s. = not-significant; *** = p &lt; 0.001 vs control, post-hoc independent samples t-test following two-way ANOVA, with postnatal age and treatment as the independent variables. </plain></SENT>
</text></p></caption><graphic xlink:href="gr7"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p><text><SENT sid="407" pm="."><plain>A summary of the impact of development and γ-CD, or finasteride preincubation on the mIPSC properties of WT L2/3 pyramidal neurons.* = p &lt; 0.05,*** = p &lt; 0.001, vs control, unpaired t-test.††† = p &lt; 0.001, vs control, one way ANOVA with Tukey post hoc test. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3"><text><SENT sid="408" pm="."><plain>P7/8 </plain></SENT>
</text></th><th colspan="2"><text><SENT sid="409" pm="."><plain>P10 </plain></SENT>
</text></th><th colspan="2"><text><SENT sid="410" pm="."><plain>P15 </plain></SENT>
</text></th><th colspan="3"><text><SENT sid="411" pm="."><plain>P20-24 </plain></SENT>
</text></th></tr><tr><th><text><SENT sid="412" pm="."><plain>Control(n = 55) </plain></SENT>
</text></th><th><text><SENT sid="413" pm="."><plain>γ-CD(n = 20) </plain></SENT>
</text></th><th><text><SENT sid="414" pm="."><plain>FIN(n = 7) </plain></SENT>
</text></th><th><text><SENT sid="415" pm="."><plain>Control(n = 20) </plain></SENT>
</text></th><th><text><SENT sid="416" pm="."><plain>γ-CD(n = 11) </plain></SENT>
</text></th><th><text><SENT sid="417" pm="."><plain>Control(n = 14) </plain></SENT>
</text></th><th><text><SENT sid="418" pm="."><plain>γ-CD(n = 12) </plain></SENT>
</text></th><th><text><SENT sid="419" pm="."><plain>Control(n = 25) </plain></SENT>
</text></th><th><text><SENT sid="420" pm="."><plain>γ-CD(n = 8) </plain></SENT>
</text></th><th><text><SENT sid="421" pm="."><plain>FIN(n = 6) </plain></SENT>
</text></th></tr></thead><tbody><tr><td><text><SENT sid="422" pm="."><plain>Peak amplitude (pA) </plain></SENT>
</text></td><td align="char"><text><SENT sid="423" pm="."><plain>−50 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="424" pm="."><plain>−48 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="425" pm="."><plain>−63 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="426" pm="."><plain>−46 ± 2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="427" pm="."><plain>−47 ± 4 </plain></SENT>
</text></td><td align="char"><text><SENT sid="428" pm="."><plain>−54 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="429" pm="."><plain>−45 ± 1* </plain></SENT>
</text></td><td align="char"><text><SENT sid="430" pm="."><plain>−42 ± 2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="431" pm="."><plain>−42 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="432" pm="."><plain>−50 ± 5 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="433" pm="."><plain>Rise time (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="434" pm="."><plain>0.6 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="435" pm="."><plain>0.6 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="436" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="437" pm="."><plain>0.6 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="438" pm="."><plain>0.6 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="439" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="440" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="441" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="442" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="443" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="444" pm="."><plain>τW (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="445" pm="."><plain>12.1 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="446" pm="."><plain>8.5 ± 0.2††† </plain></SENT>
</text></td><td align="char"><text><SENT sid="447" pm="."><plain>8.5 ± 0.3††† </plain></SENT>
</text></td><td align="char"><text><SENT sid="448" pm="."><plain>10.5 ± 0.5 </plain></SENT>
</text></td><td align="char"><text><SENT sid="449" pm="."><plain>7.3 ± 0.4*** </plain></SENT>
</text></td><td align="char"><text><SENT sid="450" pm="."><plain>6.5 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="451" pm="."><plain>5.2 ± 0.3* </plain></SENT>
</text></td><td align="char"><text><SENT sid="452" pm="."><plain>5.4 ± 0.2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="453" pm="."><plain>5.3 ± 0.6 </plain></SENT>
</text></td><td align="char"><text><SENT sid="454" pm="."><plain>5.3 ± 0.2 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="455" pm="."><plain>Frequency (Hz) </plain></SENT>
</text></td><td align="char"><text><SENT sid="456" pm="."><plain>1.2 ± 0.2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="457" pm="."><plain>1.2 ± 0.2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="458" pm="."><plain>1.8 ± 0.4 </plain></SENT>
</text></td><td align="char"><text><SENT sid="459" pm="."><plain>2.2 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="460" pm="."><plain>2.6 ± 0.5 </plain></SENT>
</text></td><td align="char"><text><SENT sid="461" pm="."><plain>12.9 ± 2.0 </plain></SENT>
</text></td><td align="char"><text><SENT sid="462" pm="."><plain>12.4 ± 2.8 </plain></SENT>
</text></td><td align="char"><text><SENT sid="463" pm="."><plain>11.7 ± 1.2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="464" pm="."><plain>12.6 ± 3.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="465" pm="."><plain>9.1 ± 0.7 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p><text><SENT sid="466" pm="."><plain>A summary of the impact of development and γ-CD pre-incubation on the properties of mIPSCs of α1−/−L2/3 pyramidal neurons.** = p &lt; 0.01,*** = p &lt; 0.001, vs control, Student's unpaired t-test.† = p &lt; 0.05,†† = p &lt; 0.01, vs control, one way ANOVA with Tukey post hoc analysis. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3"><text><SENT sid="467" pm="."><plain>P7-8 </plain></SENT>
</text></th><th colspan="2"><text><SENT sid="468" pm="."><plain>P10 </plain></SENT>
</text></th><th colspan="2"><text><SENT sid="469" pm="."><plain>P15 </plain></SENT>
</text></th><th colspan="3"><text><SENT sid="470" pm="."><plain>P20-24 </plain></SENT>
</text></th></tr><tr><th><text><SENT sid="471" pm="."><plain>Control(n = 5) </plain></SENT>
</text></th><th><text><SENT sid="472" pm="."><plain>γ-CD(n = 8) </plain></SENT>
</text></th><th><text><SENT sid="473" pm="."><plain>FIN(n = 5) </plain></SENT>
</text></th><th><text><SENT sid="474" pm="."><plain>Control(n = 4) </plain></SENT>
</text></th><th><text><SENT sid="475" pm="."><plain>γ-CD(n = 4) </plain></SENT>
</text></th><th><text><SENT sid="476" pm="."><plain>Control(n = 12) </plain></SENT>
</text></th><th><text><SENT sid="477" pm="."><plain>γ-CD(n = 9) </plain></SENT>
</text></th><th><text><SENT sid="478" pm="."><plain>Control(n = 13) </plain></SENT>
</text></th><th><text><SENT sid="479" pm="."><plain>γ-CD(n = 11) </plain></SENT>
</text></th><th><text><SENT sid="480" pm="."><plain>FIN(n = 7) </plain></SENT>
</text></th></tr></thead><tbody><tr><td><text><SENT sid="481" pm="."><plain>Peak amplitude (pA) </plain></SENT>
</text></td><td align="char"><text><SENT sid="482" pm="."><plain>−57 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="483" pm="."><plain>−52 ± 2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="484" pm="."><plain>−60 ± 6 </plain></SENT>
</text></td><td align="char"><text><SENT sid="485" pm="."><plain>−49 ± 2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="486" pm="."><plain>−51 ± 6 </plain></SENT>
</text></td><td align="char"><text><SENT sid="487" pm="."><plain>−41 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="488" pm="."><plain>−39 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="489" pm="."><plain>−49 ± 3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="490" pm="."><plain>−47 ± 2 </plain></SENT>
</text></td><td align="char"><text><SENT sid="491" pm="."><plain>−57 ± 3.8 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="492" pm="."><plain>Rise time (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="493" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="494" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="495" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="496" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="497" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="498" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="499" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="500" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="501" pm="."><plain>0.5 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="502" pm="."><plain>0.4 ± 0.1 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="503" pm="."><plain>τW (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="504" pm="."><plain>18.7 ± 2.0 </plain></SENT>
</text></td><td align="char"><text><SENT sid="505" pm="."><plain>12.2 ± 1.0†† </plain></SENT>
</text></td><td align="char"><text><SENT sid="506" pm="."><plain>12.9 ± 0.9† </plain></SENT>
</text></td><td align="char"><text><SENT sid="507" pm="."><plain>16.0 ± 1.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="508" pm="."><plain>9.2 ± 1.1*** </plain></SENT>
</text></td><td align="char"><text><SENT sid="509" pm="."><plain>13.5 ± 0.9 </plain></SENT>
</text></td><td align="char"><text><SENT sid="510" pm="."><plain>9.8 ± 0.4** </plain></SENT>
</text></td><td align="char"><text><SENT sid="511" pm="."><plain>7.9 ± 0.4 </plain></SENT>
</text></td><td align="char"><text><SENT sid="512" pm="."><plain>7.9 ± 0.6 </plain></SENT>
</text></td><td align="char"><text><SENT sid="513" pm="."><plain>8.8 ± 0.4 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="514" pm="."><plain>Frequency (Hz) </plain></SENT>
</text></td><td><text><SENT sid="515" pm="."><plain>ND </plain></SENT>
</text></td><td><text><SENT sid="516" pm="."><plain>ND </plain></SENT>
</text></td><td><text><SENT sid="517" pm="."><plain>ND </plain></SENT>
</text></td><td align="char"><text><SENT sid="518" pm="."><plain>0.8 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="519" pm="."><plain>1.5 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="520" pm="."><plain>3.9 ± 0.7 </plain></SENT>
</text></td><td align="char"><text><SENT sid="521" pm="."><plain>3.5 ± 1.0 </plain></SENT>
</text></td><td align="char"><text><SENT sid="522" pm="."><plain>12.5 ± 1.6 </plain></SENT>
</text></td><td align="char"><text><SENT sid="523" pm="."><plain>8.5 ± 1.2 </plain></SENT>
</text></td><td><text><SENT sid="524" pm="."><plain>ND </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><p><text><SENT sid="525" pm="."><plain>A summary of the effects of intracellular γ-CD treatment on the properties of mIPSCs of L2/3 GAD 67 GFP + neurons.*** = p &lt; 0.001, vs control, unpaired t-test. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th><text><SENT sid="526" pm="."><plain>P7 control(n = 8) </plain></SENT>
</text></th><th><text><SENT sid="527" pm="."><plain>P7 γ-CD(n = 8) </plain></SENT>
</text></th><th><text><SENT sid="528" pm="."><plain>P20-24 control(n = 14) </plain></SENT>
</text></th><th><text><SENT sid="529" pm="."><plain>P20-24 γ-CD(n = 7) </plain></SENT>
</text></th></tr></thead><tbody><tr><td><text><SENT sid="530" pm="."><plain>Peak amplitude (pA) </plain></SENT>
</text></td><td align="char"><text><SENT sid="531" pm="."><plain>−74 ± 7 </plain></SENT>
</text></td><td align="char"><text><SENT sid="532" pm="."><plain>−61 ± 5 </plain></SENT>
</text></td><td align="char"><text><SENT sid="533" pm="."><plain>−62 ± 4 </plain></SENT>
</text></td><td align="char"><text><SENT sid="534" pm="."><plain>−59 ± 7 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="535" pm="."><plain>Rise time (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="536" pm="."><plain>0.4 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="537" pm="."><plain>0.4 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="538" pm="."><plain>0.4 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="539" pm="."><plain>0.4 ± 0.1 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="540" pm="."><plain>τW (ms) </plain></SENT>
</text></td><td align="char"><text><SENT sid="541" pm="."><plain>11.7 ± 0.8 </plain></SENT>
</text></td><td align="char"><text><SENT sid="542" pm="."><plain>7.6 ± 0.2*** </plain></SENT>
</text></td><td align="char"><text><SENT sid="543" pm="."><plain>4.5 ± 0.3 </plain></SENT>
</text></td><td align="char"><text><SENT sid="544" pm="."><plain>4.0 ± 0.4 </plain></SENT>
</text></td></tr><tr><td><text><SENT sid="545" pm="."><plain>Frequency (Hz) </plain></SENT>
</text></td><td align="char"><text><SENT sid="546" pm="."><plain>0.3 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="547" pm="."><plain>0.2 ± 0.1 </plain></SENT>
</text></td><td align="char"><text><SENT sid="548" pm="."><plain>2.7 ± 0.5 </plain></SENT>
</text></td><td align="char"><text><SENT sid="549" pm="."><plain>2.1 ± 0.9 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></floats-group></article>
